| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP hydrolysis activity | SMARCAD1 ABCB1 ABCB4 HSPA13 HFM1 DHX29 TAP1 DNAH9 KIF6 ABCB5 ABCB6 YTHDC2 INO80 MORC2 RFC5 IGHMBP2 MACF1 | 6.22e-05 | 441 | 257 | 17 | GO:0016887 |
| GeneOntologyBiologicalProcess | neuron development | USP9X TRPC6 SRF LGR4 CDH23 TSC2 PCDH12 PTCH1 TTC3 WNK1 ASAP1 ITPR1 NEFM FES HERC1 CACNA1A RPGRIP1 CUX2 RASGRF1 KALRN SYNE1 SAMD4B LAMB1 FRYL VPS54 SEMA4G CASK PALS1 FRY CSF1R LINGO1 CELSR2 TMEM132E FARP1 MACF1 ROBO1 GRIP2 VPS13B CUX1 | 4.92e-06 | 1463 | 256 | 39 | GO:0048666 |
| GeneOntologyBiologicalProcess | reciprocal meiotic recombination | 1.93e-05 | 67 | 256 | 7 | GO:0007131 | |
| GeneOntologyBiologicalProcess | reciprocal homologous recombination | 1.93e-05 | 67 | 256 | 7 | GO:0140527 | |
| GeneOntologyBiologicalProcess | localization within membrane | RAPGEF6 TSC2 PTCH1 WNK1 ASAP1 TTC7B MIEF1 GRIN3B WDR72 DOCK2 CACNA1A CACNB2 KALRN LZTFL1 GRIK5 ANKRD50 EPG5 CASK PALS1 GCC2 FARP1 MACF1 GRIP2 VPS13B LARGE1 | 2.21e-05 | 798 | 256 | 25 | GO:0051668 |
| GeneOntologyBiologicalProcess | protein localization to cell periphery | RAPGEF6 TSC2 PTCH1 WNK1 ASAP1 TTC7B WDR72 CACNB2 KALRN LZTFL1 NUMA1 CASK PALS1 GCC2 MACF1 GRIP2 LARGE1 | 2.29e-05 | 422 | 256 | 17 | GO:1990778 |
| GeneOntologyBiologicalProcess | male gamete generation | NR2C2 CATSPERD TCP11X2 IQCF1 LGR4 PTCH1 CEP128 NME8 FSIP2 HFM1 CFAP70 TAF4B ZMYND12 UBR2 DMXL2 SYNE1 LZTFL1 YTHDC2 APOB VPS54 CNTD1 MROH2B ATM VPS13B | 2.98e-05 | 762 | 256 | 24 | GO:0048232 |
| GeneOntologyBiologicalProcess | homologous recombination | 3.70e-05 | 74 | 256 | 7 | GO:0035825 | |
| GeneOntologyBiologicalProcess | sexual reproduction | IGSF8 ANKRD31 NR2C2 EME1 CATSPERD TCP11X2 IQCF1 USP9X TRPC6 LGR4 PTCH1 CEP128 NME8 ITPR1 FSIP2 KMT2C PRR19 HFM1 CFAP70 TAF4B ZMYND12 UBR2 DMXL2 SYNE1 LZTFL1 NUMA1 YTHDC2 APOB VPS54 MORC2 CNTD1 MROH2B ATM VPS13B | 3.79e-05 | 1312 | 256 | 34 | GO:0019953 |
| GeneOntologyBiologicalProcess | microtubule-based process | STAG1 CATSPERD IQCF1 IFT172 CUL9 CEP128 LYST NME8 NEFM FSIP2 FES CFAP70 DNAH9 ZMYND12 TBCEL WDR72 KIF6 LZTFL1 NUMA1 APOB INO80 CELSR2 SBDS GCC2 PDE4DIP MACF1 CCDC120 CEP295 PCNT | 5.56e-05 | 1058 | 256 | 29 | GO:0007017 |
| GeneOntologyBiologicalProcess | spermatogenesis | NR2C2 CATSPERD TCP11X2 IQCF1 LGR4 PTCH1 CEP128 NME8 FSIP2 HFM1 CFAP70 TAF4B ZMYND12 UBR2 DMXL2 SYNE1 LZTFL1 YTHDC2 APOB VPS54 CNTD1 MROH2B VPS13B | 5.83e-05 | 744 | 256 | 23 | GO:0007283 |
| GeneOntologyBiologicalProcess | neuron projection development | USP9X TRPC6 SRF LGR4 CDH23 TSC2 PTCH1 TTC3 ASAP1 ITPR1 NEFM FES HERC1 CACNA1A CUX2 RASGRF1 KALRN SYNE1 LAMB1 FRYL VPS54 SEMA4G CASK FRY CSF1R LINGO1 CELSR2 FARP1 MACF1 ROBO1 VPS13B CUX1 | 1.37e-04 | 1285 | 256 | 32 | GO:0031175 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | USP9X TRPC6 SRF LGR4 CDH23 TSC2 PTCH1 TTC3 NEFM CACNA1A CUX2 KALRN SYNE1 LAMB1 SEMA4G CASK CSF1R CELSR2 FARP1 MACF1 ROBO1 CUX1 | 1.73e-04 | 748 | 256 | 22 | GO:0048667 |
| GeneOntologyBiologicalProcess | brain development | NR2C2 USP9X IFT172 SRF PTCH1 SSTR4 HERC1 NIPBL CACNA1A DMXL2 FOXP2 SAMD4B LAMB1 ABCB6 PALS1 AATK CSF1R CELSR2 ROBO1 IRS2 ATM VPS13B PCNT LARGE1 | 1.89e-04 | 859 | 256 | 24 | GO:0007420 |
| GeneOntologyBiologicalProcess | dendrite morphogenesis | 1.92e-04 | 198 | 256 | 10 | GO:0048813 | |
| GeneOntologyBiologicalProcess | protein localization to membrane | RAPGEF6 TSC2 PTCH1 WNK1 ASAP1 TTC7B MIEF1 GRIN3B WDR72 CACNA1A CACNB2 KALRN LZTFL1 GRIK5 CASK PALS1 GCC2 FARP1 MACF1 GRIP2 LARGE1 | 2.05e-04 | 705 | 256 | 21 | GO:0072657 |
| GeneOntologyBiologicalProcess | head development | NR2C2 USP9X IFT172 SRF PTCH1 SSTR4 HERC1 NIPBL CACNA1A DMXL2 SCHIP1 FOXP2 SAMD4B LAMB1 ABCB6 PALS1 AATK CSF1R CELSR2 ROBO1 IRS2 ATM VPS13B PCNT LARGE1 | 2.08e-04 | 919 | 256 | 25 | GO:0060322 |
| GeneOntologyBiologicalProcess | protein localization to plasma membrane | RAPGEF6 PTCH1 WNK1 ASAP1 TTC7B WDR72 CACNB2 CASK PALS1 GCC2 MACF1 GRIP2 LARGE1 | 2.20e-04 | 324 | 256 | 13 | GO:0072659 |
| GeneOntologyBiologicalProcess | gamete generation | NR2C2 CATSPERD TCP11X2 IQCF1 USP9X LGR4 PTCH1 CEP128 NME8 FSIP2 HFM1 CFAP70 TAF4B ZMYND12 UBR2 DMXL2 SYNE1 LZTFL1 YTHDC2 APOB VPS54 MORC2 CNTD1 MROH2B ATM VPS13B | 2.37e-04 | 982 | 256 | 26 | GO:0007276 |
| Domain | ARM-type_fold | STAG1 USP9X IFT172 CUL9 TSC2 TEX10 LYST ITPR1 XPO6 ARMH3 AGBL1 NIPBL TARBP1 DOCK2 PPP4R1 INTS7 DOCK9 UBR4 USP24 APOB FRYL CEBPZ UNC45B MROH2B INTS4 ATM WDFY3 | 1.18e-13 | 339 | 251 | 27 | IPR016024 |
| Domain | ARM-like | STAG1 USP9X CUL9 TSC2 TEX10 XPO6 AGBL1 NIPBL TARBP1 DOCK2 PPP4R1 INTS7 FRYL UNC45B MROH2B INTS4 WDFY3 | 1.56e-07 | 270 | 251 | 17 | IPR011989 |
| Domain | PH_dom-like | DOK5 ARHGEF11 LYST ASAP1 SPTBN5 PTPN4 RASA4B RASGRF1 KALRN DOCK9 CNKSR2 CMIP RASA4 FARP1 TLN1 IRS2 WDFY3 PLCH1 SNTB1 PLCE1 | 1.38e-06 | 426 | 251 | 20 | IPR011993 |
| Domain | PH | DOK5 ARHGEF11 ASAP1 SPTBN5 RASA4B RASGRF1 KALRN DOCK9 CNKSR2 CMIP RASA4 FARP1 IRS2 PLCH1 SNTB1 | 5.73e-06 | 278 | 251 | 15 | SM00233 |
| Domain | PH_DOMAIN | DOK5 ARHGEF11 ASAP1 SPTBN5 RASA4B RASGRF1 KALRN DOCK9 CNKSR2 CMIP RASA4 FARP1 IRS2 PLCH1 SNTB1 | 5.98e-06 | 279 | 251 | 15 | PS50003 |
| Domain | PH_domain | DOK5 ARHGEF11 ASAP1 SPTBN5 RASA4B RASGRF1 KALRN DOCK9 CNKSR2 CMIP RASA4 FARP1 IRS2 PLCH1 SNTB1 | 6.25e-06 | 280 | 251 | 15 | IPR001849 |
| Domain | - | USP9X CUL9 TSC2 TEX10 XPO6 NIPBL PPP4R1 INTS7 FRYL UNC45B MROH2B INTS4 WDFY3 | 1.02e-05 | 222 | 251 | 13 | 1.25.10.10 |
| Domain | ABC_membrane | 1.45e-05 | 24 | 251 | 5 | PF00664 | |
| Domain | - | DOK5 ARHGEF11 ASAP1 SPTBN5 PTPN4 RASA4B RASGRF1 KALRN DOCK9 CNKSR2 RASA4 FARP1 TLN1 IRS2 PLCH1 SNTB1 PLCE1 | 2.34e-05 | 391 | 251 | 17 | 2.30.29.30 |
| Domain | ABC_TM1F | 3.22e-05 | 28 | 251 | 5 | PS50929 | |
| Domain | ABC1_TM_dom | 3.22e-05 | 28 | 251 | 5 | IPR011527 | |
| Domain | - | ANKRD31 TRPC6 ASAP1 ASB11 NFKBIB ANKDD1B TRPV6 ABTB2 ANKFY1 YTHDC2 ANKRD50 ANKRD44 TRPV5 | 3.27e-05 | 248 | 251 | 13 | 1.25.40.20 |
| Domain | Ank_2 | ANKRD31 TRPC6 ASAP1 ASB11 NFKBIB ANKDD1B TRPV6 ABTB2 ANKFY1 ANKRD50 ANKRD44 TRPV5 | 3.58e-05 | 215 | 251 | 12 | PF12796 |
| Domain | ANK | ANKRD31 TRPC6 ASAP1 ASB11 NFKBIB ANKDD1B TRPV6 ABTB2 ANKFY1 YTHDC2 ANKRD50 ANKRD44 TRPV5 | 3.71e-05 | 251 | 251 | 13 | SM00248 |
| Domain | ANK_REPEAT | ANKRD31 TRPC6 ASAP1 ASB11 NFKBIB ANKDD1B TRPV6 ABTB2 ANKFY1 YTHDC2 ANKRD50 ANKRD44 TRPV5 | 4.03e-05 | 253 | 251 | 13 | PS50088 |
| Domain | Ankyrin_rpt-contain_dom | ANKRD31 TRPC6 ASAP1 ASB11 NFKBIB ANKDD1B TRPV6 ABTB2 ANKFY1 YTHDC2 ANKRD50 ANKRD44 TRPV5 | 4.19e-05 | 254 | 251 | 13 | IPR020683 |
| Domain | ANK_REP_REGION | ANKRD31 TRPC6 ASAP1 ASB11 NFKBIB ANKDD1B TRPV6 ABTB2 ANKFY1 YTHDC2 ANKRD50 ANKRD44 TRPV5 | 4.19e-05 | 254 | 251 | 13 | PS50297 |
| Domain | Ankyrin_rpt | ANKRD31 TRPC6 ASAP1 ASB11 NFKBIB ANKDD1B TRPV6 ABTB2 ANKFY1 YTHDC2 ANKRD50 ANKRD44 TRPV5 | 5.76e-05 | 262 | 251 | 13 | IPR002110 |
| Domain | PH | DOK5 ASAP1 SPTBN5 RASA4B RASGRF1 KALRN DOCK9 CNKSR2 RASA4 FARP1 IRS2 SNTB1 | 6.60e-05 | 229 | 251 | 12 | PF00169 |
| Domain | PDZ | 1.24e-04 | 141 | 251 | 9 | PF00595 | |
| Domain | PDZ | 1.79e-04 | 148 | 251 | 9 | SM00228 | |
| Domain | Cell_morpho_N | 1.80e-04 | 2 | 251 | 2 | IPR025614 | |
| Domain | Cell_Morphogen_C | 1.80e-04 | 2 | 251 | 2 | IPR025481 | |
| Domain | TRPV5/TRPV6 | 1.80e-04 | 2 | 251 | 2 | IPR008344 | |
| Domain | MOR2-PAG1_mid | 1.80e-04 | 2 | 251 | 2 | IPR029473 | |
| Domain | Cohesin_HEAT | 1.80e-04 | 2 | 251 | 2 | PF12765 | |
| Domain | MOR2-PAG1_mid | 1.80e-04 | 2 | 251 | 2 | PF14228 | |
| Domain | MOR2-PAG1_C | 1.80e-04 | 2 | 251 | 2 | PF14225 | |
| Domain | MOR2-PAG1_N | 1.80e-04 | 2 | 251 | 2 | PF14222 | |
| Domain | Cohesin_HEAT | 1.80e-04 | 2 | 251 | 2 | IPR026003 | |
| Domain | - | 1.98e-04 | 150 | 251 | 9 | 2.30.42.10 | |
| Domain | PDZ | 2.09e-04 | 151 | 251 | 9 | PS50106 | |
| Domain | PDZ | 2.19e-04 | 152 | 251 | 9 | IPR001478 | |
| Domain | Spectrin | 2.31e-04 | 23 | 251 | 4 | PF00435 | |
| Domain | ABC_transporter_CS | 2.39e-04 | 42 | 251 | 5 | IPR017871 | |
| Domain | L27_C | 2.68e-04 | 10 | 251 | 3 | IPR014775 | |
| Domain | L27 | 2.68e-04 | 10 | 251 | 3 | PF02828 | |
| Domain | Ank | ANKRD31 TRPC6 ASAP1 ASB11 NFKBIB TRPV6 ABTB2 ANKFY1 ANKRD50 ANKRD44 TRPV5 | 2.72e-04 | 228 | 251 | 11 | PF00023 |
| Domain | TRP_channel | 3.65e-04 | 11 | 251 | 3 | IPR004729 | |
| Domain | Guanylate_kin | 3.77e-04 | 26 | 251 | 4 | PF00625 | |
| Domain | GK/Ca_channel_bsu | 3.77e-04 | 26 | 251 | 4 | IPR008145 | |
| Domain | Guanylate_kin-like_dom | 3.77e-04 | 26 | 251 | 4 | IPR008144 | |
| Domain | GuKc | 3.77e-04 | 26 | 251 | 4 | SM00072 | |
| Domain | ABC_tran | 4.50e-04 | 48 | 251 | 5 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 4.50e-04 | 48 | 251 | 5 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 4.96e-04 | 49 | 251 | 5 | PS00211 | |
| Domain | - | 5.35e-04 | 3 | 251 | 2 | 4.10.1130.10 | |
| Domain | ABC_transporter-like | 5.45e-04 | 50 | 251 | 5 | IPR003439 | |
| Domain | Spectrin_repeat | 5.81e-04 | 29 | 251 | 4 | IPR002017 | |
| Domain | L27 | 6.21e-04 | 13 | 251 | 3 | SM00569 | |
| Domain | L27 | 6.21e-04 | 13 | 251 | 3 | PS51022 | |
| Domain | L27_dom | 6.21e-04 | 13 | 251 | 3 | IPR004172 | |
| Domain | Cadherin_CS | 6.78e-04 | 109 | 251 | 7 | IPR020894 | |
| Domain | AAA | 7.45e-04 | 144 | 251 | 8 | SM00382 | |
| Domain | AAA+_ATPase | 7.45e-04 | 144 | 251 | 8 | IPR003593 | |
| Domain | IRS | 7.82e-04 | 14 | 251 | 3 | PF02174 | |
| Domain | IRS_PTB | 7.82e-04 | 14 | 251 | 3 | IPR002404 | |
| Domain | CADHERIN_1 | 8.39e-04 | 113 | 251 | 7 | PS00232 | |
| Domain | Cadherin | 8.39e-04 | 113 | 251 | 7 | PF00028 | |
| Domain | SPEC | 8.52e-04 | 32 | 251 | 4 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 8.52e-04 | 32 | 251 | 4 | IPR018159 | |
| Domain | CADHERIN_2 | 8.84e-04 | 114 | 251 | 7 | PS50268 | |
| Domain | - | 8.84e-04 | 114 | 251 | 7 | 2.60.40.60 | |
| Domain | CA | 9.31e-04 | 115 | 251 | 7 | SM00112 | |
| Domain | Cadherin-like | 9.80e-04 | 116 | 251 | 7 | IPR015919 | |
| Domain | Tcp11 | 1.06e-03 | 4 | 251 | 2 | IPR008862 | |
| Domain | Tcp11 | 1.06e-03 | 4 | 251 | 2 | PF05794 | |
| Domain | Cadherin | 1.08e-03 | 118 | 251 | 7 | IPR002126 | |
| Domain | Guanylate_kinase_CS | 1.18e-03 | 16 | 251 | 3 | IPR020590 | |
| Domain | Autophagy-rel_C | 1.75e-03 | 5 | 251 | 2 | IPR015412 | |
| Domain | ATG_C | 1.75e-03 | 5 | 251 | 2 | PF09333 | |
| Domain | Cadherin_2 | 1.80e-03 | 65 | 251 | 5 | PF08266 | |
| Domain | Cadherin_N | 1.80e-03 | 65 | 251 | 5 | IPR013164 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | GADD45B RAPGEF6 KDM3B CUL9 TSC2 ATG2A PTCH1 ARHGEF11 TTC3 WNK1 LYST SLC52A3 PCNX2 KMT2C TNRC18 XPO6 UNKL HES6 HERC1 ABTB2 IQCE KALRN DOCK9 UBR4 HECTD4 FRYL INO80 HDDC3 NADSYN1 AATK CELSR2 SLC16A5 TLN1 ZFYVE26 IRS2 TNFAIP2 WDFY3 PCNT | 4.32e-15 | 1105 | 259 | 38 | 35748872 |
| Pubmed | IFT172 CUL9 FAM91A1 SMARCAD1 KLHL32 ASAP1 PJA2 PCDH19 DOP1B UBR2 ANKFY1 SYNE1 DOCK9 CNKSR2 EPG5 GCC2 TLN1 PDE4DIP MACF1 VPS13B PCNT PLCE1 LARGE1 | 7.29e-14 | 407 | 259 | 23 | 12693553 | |
| Pubmed | USP9X TSC2 TRIM21 TEX10 ARHGEF11 TTC3 NEFM NIPBL GOLGB1 MPP2 CACNA1A CACNB2 DMXL2 ANKFY1 FOXP2 KALRN SYNE1 UBR4 HECTD4 NUMA1 CNKSR2 GRIK5 CASK PALS1 FRY CELSR2 FARP1 PDE4DIP MACF1 WDFY3 CUX1 PCNT | 1.89e-12 | 963 | 259 | 32 | 28671696 | |
| Pubmed | KDM3B WNK1 KMT2C XPO6 DOP1B DMXL2 CUX2 ANKFY1 SYNE1 DOCK9 AATK TLN1 MACF1 GRIP2 WDFY3 PCNT | 1.68e-11 | 225 | 259 | 16 | 12168954 | |
| Pubmed | NR2C2 MCMBP ACADSB RRP1B CCDC18 FASTKD5 SMARCAD1 RB1CC1 TTC3 ITPR1 HSPA13 PJA2 DHX29 GOLGB1 DMXL2 SYNE1 UBR4 LAMB1 LRRC40 CASK TBC1D8 DNAJC17 CEBPZ MRPS2 FARP1 TLN1 GKAP1 MACF1 ROBO1 ATM CRYBG3 PLCH1 DCXR SNTB1 VPS13B CUX1 PCNT | 1.39e-10 | 1487 | 259 | 37 | 33957083 | |
| Pubmed | STAG1 USP9X IFT172 CUL9 TSC2 SMARCAD1 TTC3 STAT6 HSPA13 NEFM TTC7B MVP NIPBL TARBP1 DOP1B PPP4R1 DMXL2 KALRN SYNE1 UBR4 POLR2C HECTD4 LAMB1 VPS54 CASK NFE2L3 FRY PDE4DIP MACF1 ROBO1 ATM WDFY3 CUX1 PCNT | 1.72e-10 | 1285 | 259 | 34 | 35914814 | |
| Pubmed | STAT6 PCNX2 KMT2C TTC7B UNKL IQCE CACNA1A ZFAT KALRN SYNE1 UBR4 YTHDC2 PDE4DIP CEP295 | 2.86e-09 | 233 | 259 | 14 | 37704626 | |
| Pubmed | EME1 STAG1 NOL6 TEX10 TTC3 CEP128 LYST ABCB1 ABCB4 NEFM TNRC18 NIPBL GOLGB1 RPGRIP1 CUX2 PCDHGB5 SYNE1 PCDHGA2 ABCB5 UBR4 COQ6 NUMA1 CCDC150 APOB SRBD1 NFE2L3 CEBPZ PCDHGB4 MACF1 CEP295 ATM PLCH1 CUX1 PCNT | 3.28e-09 | 1442 | 259 | 34 | 35575683 | |
| Pubmed | RAPGEF6 LGR4 FAM91A1 PTCH1 TTC3 WNK1 KLHL32 ASAP1 STAT6 ITPR1 PHKB KMT2C WWC2 HERC1 GOLGB1 CCHCR1 CACNB2 DOCK9 APOB FRYL NUDT16L1 INO80 ANKRD50 TCP11L2 FARP1 MACF1 CEP295 VPS13B PCNT | 3.31e-09 | 1084 | 259 | 29 | 11544199 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | STAG1 USP9X IFT172 ITPR1 PHKB TTC7B DHX29 CACNA1A LRRC8C KALRN INTS7 UBR4 USP24 YTHDC2 INO80 MORC2 CASK FRY | 2.28e-08 | 475 | 259 | 18 | 31040226 |
| Pubmed | MCMBP RRP1B USP9X CCDC18 FAM91A1 RB1CC1 TEX10 ASAP1 ITPR1 PHKB PTPN4 WWC2 TTC7B HERC1 PPP4R1 UBR2 POLR2C USP46 CASK CEBPZ PPM1F FARP1 INTS4 ROBO1 CRYBG3 SNTB1 PCNT | 2.65e-08 | 1049 | 259 | 27 | 27880917 | |
| Pubmed | ACADSB USP9X NOL6 KDM3B NFKBIB HFM1 NIPBL TARBP1 ANKFY1 UBR4 USP24 POLR1E MRPS2 PPM1F GCC2 GYS1 CEP295 IRS2 WDFY3 CUX1 | 8.43e-08 | 638 | 259 | 20 | 31182584 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | RAPGEF6 SMARCAD1 ATG2A PTCH1 WNK1 ASAP1 TNRC18 IQCE CUX2 UBR4 NUMA1 CNKSR2 AATK TLN1 ATM PCNT | 1.79e-07 | 430 | 259 | 16 | 35044719 |
| Pubmed | PCDH12 TTC3 WNK1 ASAP1 RABGGTB DMXL2 ZFAT ANKFY1 KALRN SYNE1 DOCK9 ANKRD50 TLN1 PDE4DIP INTS4 MACF1 PLCE1 | 2.41e-07 | 497 | 259 | 17 | 23414517 | |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 3.64e-07 | 38 | 259 | 6 | 30786075 | |
| Pubmed | 4.08e-07 | 3 | 259 | 3 | 9542318 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | STAG1 TRIM21 SMARCAD1 XPO6 MVP NIPBL GOLGB1 DOCK2 MPP2 USP24 LRRC40 YTHDC2 RFC5 TLN1 MACF1 TNFAIP2 ATM PCNT | 4.62e-07 | 582 | 259 | 18 | 20467437 |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | RRP1B TRIM21 RB1CC1 PTCH1 ASAP1 UNKL FOXP2 POLR2C LAMB1 CASK CELSR2 MACF1 ROBO1 IRS2 | 5.90e-07 | 358 | 259 | 14 | 32460013 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MAOA SRF TTC3 PCNX2 PHKB KMT2C PTPN4 TNRC18 SLC9A7 ALG12 GOLGB1 UBR2 CACNB2 MAN2B2 SAMD4B HECTD4 FRYL VPS54 CASK ANKRD44 CMIP NADSYN1 GCC2 FARP1 MACF1 GLIS1 VPS13B CUX1 PCNT MAF | 8.50e-07 | 1489 | 259 | 30 | 28611215 |
| Pubmed | 2.16e-06 | 151 | 259 | 9 | 17043677 | ||
| Pubmed | RRP1B USP9X NOL6 CUL9 TEX10 NEFM MVP NIPBL UBR4 USP24 NUMA1 YTHDC2 FRYL CEBPZ TLN1 MACF1 ATM PCNT | 2.36e-06 | 653 | 259 | 18 | 22586326 | |
| Pubmed | NR2C2 RAPGEF6 RB1CC1 NEFM GOLGB1 ANKFY1 UBR4 USP24 PPM1F GCC2 IRS2 CRYBG3 CUX1 PCNT | 3.61e-06 | 418 | 259 | 14 | 34709266 | |
| Pubmed | KDM5C LGR4 CUL9 FASTKD5 SMARCAD1 PJA2 ASB11 PCDH19 TAF4B AGBL1 WDR72 FOXP2 POLR2C LAMB1 C16orf96 YTHDC2 INO80 RFC5 POLR1E MACF1 CEP295 IRS2 WDFY3 CRYBG3 | 3.83e-06 | 1116 | 259 | 24 | 31753913 | |
| Pubmed | RAPGEF6 TTC7B PCDH19 GOLGB1 CACNB2 USP46 ANKRD50 CASK PALS1 CELSR2 MACF1 ROBO1 PLCH1 SNTB1 | 3.92e-06 | 421 | 259 | 14 | 36976175 | |
| Pubmed | Role and regulation of TRP channels in neutrophil granulocytes. | 4.04e-06 | 5 | 259 | 3 | 12765698 | |
| Pubmed | 4.12e-06 | 87 | 259 | 7 | 12465718 | ||
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | CMTR1 NOL6 FASTKD5 CEP128 IL17RA GOLGB1 CCHCR1 MAN2B2 INTS7 YTHDC2 CEBPZ COMMD9 MRPS2 GCC2 IGHMBP2 PDE4DIP INTS4 CUX1 PCNT | 4.52e-06 | 754 | 259 | 19 | 33060197 |
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 4.82e-06 | 212 | 259 | 10 | 33853758 | |
| Pubmed | 5.10e-06 | 16 | 259 | 4 | 26235615 | ||
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | NR2C2 ACADSB USP9X LGR4 RB1CC1 STAT6 HSPA13 HERC1 GOLGB1 WDR72 COQ6 APOB TBC1D8 CMIP CELSR2 GLCE PDE4DIP INTS4 MACF1 TNFAIP2 ATM WDFY3 CUX1 | 5.40e-06 | 1061 | 259 | 23 | 33845483 |
| Pubmed | CUL9 SPTBN5 UGT2B17 CFAP70 TAF4B DHX29 LAMB1 APOB RFC5 CASK POLR1E MRPS2 GCC2 MACF1 LARGE1 | 5.58e-06 | 496 | 259 | 15 | 31343991 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | USP9X KDM5C TEX10 ARHGEF11 KMT2C HERC1 ARMH3 DOCK9 NUMA1 YTHDC2 MORC2 RFC5 IGHMBP2 IRS2 ATM | 5.71e-06 | 497 | 259 | 15 | 36774506 |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | MCMBP ACADSB NOL6 KDM3B TRIM21 ATG2A TEX10 PJA2 OTUB2 TARBP1 ANKFY1 YTHDC2 CNKSR2 USP46 SRBD1 SKP2 CASK PALS1 POLR1E GCC2 GYS1 DCXR | 7.48e-06 | 1005 | 259 | 22 | 19615732 |
| Pubmed | Molecular cloning and characterization of Pals, proteins associated with mLin-7. | 8.03e-06 | 6 | 259 | 3 | 10753959 | |
| Pubmed | 8.03e-06 | 6 | 259 | 3 | 15488952 | ||
| Pubmed | RRP1B NOL6 FAM91A1 TEX10 ARHGEF11 KMT2C SCOC DHX29 NIPBL GOLGB1 INTS7 SYNE1 SAMD4B POLR2C ABCB6 YTHDC2 INO80 SRBD1 MORC2 RFC5 CASK CEBPZ POLR1E MRPS2 FARP1 IGHMBP2 TLN1 MACF1 | 8.16e-06 | 1497 | 259 | 28 | 31527615 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | MCMBP RAPGEF6 CCDC18 KDM3B TSC2 WNK1 LYST FSIP2 PJA2 WWC2 MIEF1 ABTB2 GOLGB1 DOP1B SAMD4B FRYL MACF1 IRS2 CRYBG3 PLCH1 | 8.38e-06 | 861 | 259 | 20 | 36931259 |
| Pubmed | RAPGEF6 NOL6 KDM3B FAM91A1 SMARCAD1 ITPR1 PPP4R1 DMXL2 SAMD4B YTHDC2 ANKRD50 MORC2 PALS1 TNFAIP2 CRYBG3 PLCH1 PLCE1 | 8.99e-06 | 650 | 259 | 17 | 38777146 | |
| Pubmed | USP9X CUL9 TEX10 TNRC18 INTS7 SAMD4B UBR4 POLR2C USP24 MACF1 CUX1 | 9.89e-06 | 282 | 259 | 11 | 23667531 | |
| Pubmed | 1.26e-05 | 103 | 259 | 7 | 10574462 | ||
| Pubmed | 1.35e-05 | 104 | 259 | 7 | 9205841 | ||
| Pubmed | 1.40e-05 | 7 | 259 | 3 | 10856136 | ||
| Pubmed | 1.55e-05 | 147 | 259 | 8 | 29576527 | ||
| Pubmed | The apical complex couples cell fate and cell survival to cerebral cortical development. | 1.98e-05 | 22 | 259 | 4 | 20399730 | |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | LGR4 RB1CC1 WNK1 ASAP1 ITPR1 TAF4B DOCK9 HECTD4 SCRN2 FARP1 PDE4DIP LARGE1 | 2.05e-05 | 363 | 259 | 12 | 14691545 |
| Pubmed | 2.09e-05 | 251 | 259 | 10 | 27507650 | ||
| Pubmed | 2.22e-05 | 8 | 259 | 3 | 21104742 | ||
| Pubmed | CMTR1 WNK1 TNRC18 TXNDC16 DOCK2 DMXL2 MAN2B2 MORC2 SEMA4G CMIP GLCE MACF1 ZNF518B PLCH1 | 2.30e-05 | 493 | 259 | 14 | 15368895 | |
| Pubmed | 2.38e-05 | 23 | 259 | 4 | 22090492 | ||
| Pubmed | MCMBP RRP1B USP9X KDM5C WNK1 DHX29 NIPBL KALRN SAMD4B USP24 NUMA1 MORC2 GCC2 IRS2 | 2.86e-05 | 503 | 259 | 14 | 16964243 | |
| Pubmed | 3.32e-05 | 9 | 259 | 3 | 20370913 | ||
| Pubmed | 3.32e-05 | 9 | 259 | 3 | 8995758 | ||
| Pubmed | 3.32e-05 | 9 | 259 | 3 | 29360985 | ||
| Pubmed | Interaction proteome of human Hippo signaling: modular control of the co-activator YAP1. | 3.89e-05 | 270 | 259 | 10 | 24366813 | |
| Pubmed | 3.95e-05 | 26 | 259 | 4 | 10920247 | ||
| Pubmed | 4.61e-05 | 27 | 259 | 4 | 18685082 | ||
| Pubmed | 4.68e-05 | 276 | 259 | 10 | 28319085 | ||
| Pubmed | IRX3/5 regulate mitotic chromatid segregation and limb bud shape. | 4.71e-05 | 10 | 259 | 3 | 32907847 | |
| Pubmed | Development and distribution of neuronal cilia in mouse neocortex. | 4.71e-05 | 10 | 259 | 3 | 22020803 | |
| Pubmed | 4.71e-05 | 10 | 259 | 3 | 17507397 | ||
| Pubmed | USP9X FAM91A1 ASAP1 ITPR1 PJA2 TNRC18 DHX29 MPP2 CACNA1A DMXL2 KALRN DOCK9 UBR4 LZTFL1 USP24 CNKSR2 CELSR2 FARP1 IGHMBP2 PDE4DIP MACF1 CRYBG3 | 4.97e-05 | 1139 | 259 | 22 | 36417873 | |
| Pubmed | 5.52e-05 | 2 | 259 | 2 | 10488067 | ||
| Pubmed | Multidrug resistance gene expression and ABCB1 SNPs in plasma cell myeloma. | 5.52e-05 | 2 | 259 | 2 | 21705081 | |
| Pubmed | 5.52e-05 | 2 | 259 | 2 | 20178461 | ||
| Pubmed | 5.52e-05 | 2 | 259 | 2 | 10552998 | ||
| Pubmed | 5.52e-05 | 2 | 259 | 2 | 22354706 | ||
| Pubmed | Genetic dissection of the function of mammalian P-glycoproteins. | 5.52e-05 | 2 | 259 | 2 | 9196326 | |
| Pubmed | Diverse calcium channel types are present in the human placental syncytiotrophoblast basal membrane. | 5.52e-05 | 2 | 259 | 2 | 16564089 | |
| Pubmed | Endogenous expression of TRPV5 and TRPV6 calcium channels in human leukemia K562 cells. | 5.52e-05 | 2 | 259 | 2 | 19295174 | |
| Pubmed | Human TRPV5 and TRPV6: key players in cadmium and zinc toxicity. | 5.52e-05 | 2 | 259 | 2 | 23968883 | |
| Pubmed | 5.52e-05 | 2 | 259 | 2 | 28356387 | ||
| Pubmed | 5.52e-05 | 2 | 259 | 2 | 16566920 | ||
| Pubmed | 5.52e-05 | 2 | 259 | 2 | 33015191 | ||
| Pubmed | TRPV5 and TRPV6 are expressed in placenta and bone tissues during pregnancy in mice. | 5.52e-05 | 2 | 259 | 2 | 30916584 | |
| Pubmed | 5.52e-05 | 2 | 259 | 2 | 8898203 | ||
| Pubmed | 5.52e-05 | 2 | 259 | 2 | 35581205 | ||
| Pubmed | 5.52e-05 | 2 | 259 | 2 | 2473069 | ||
| Pubmed | 5.52e-05 | 2 | 259 | 2 | 19185004 | ||
| Pubmed | Coding variants in the PCNT and CEP295 genes contribute to breast cancer risk in Chinese women. | 5.52e-05 | 2 | 259 | 2 | 34418690 | |
| Pubmed | A single amino acid mutation results in a rapid inactivation of epithelial calcium channels. | 5.52e-05 | 2 | 259 | 2 | 11846401 | |
| Pubmed | 5.52e-05 | 2 | 259 | 2 | 24761864 | ||
| Pubmed | 5.52e-05 | 2 | 259 | 2 | 38264642 | ||
| Pubmed | Mammalian class theta GST and differential susceptibility to carcinogens: a review. | 5.52e-05 | 2 | 259 | 2 | 11018744 | |
| Pubmed | 5.52e-05 | 2 | 259 | 2 | 8617493 | ||
| Pubmed | 5.52e-05 | 2 | 259 | 2 | 12077127 | ||
| Pubmed | 5.52e-05 | 2 | 259 | 2 | 24592736 | ||
| Pubmed | 5.52e-05 | 2 | 259 | 2 | 25521631 | ||
| Pubmed | 5.52e-05 | 2 | 259 | 2 | 9029166 | ||
| Pubmed | Biliary secretion of alpha-tocopherol and the role of the mdr2 P-glycoprotein in rats and mice. | 5.52e-05 | 2 | 259 | 2 | 9473291 | |
| Pubmed | 5.52e-05 | 2 | 259 | 2 | 12429822 | ||
| Pubmed | 5.52e-05 | 2 | 259 | 2 | 2471060 | ||
| Pubmed | MDR1 and MDR3 genes and drug resistance to cisplatin of ovarian cancer cells. | 5.52e-05 | 2 | 259 | 2 | 18231753 | |
| Pubmed | Structural conservation of the genes encoding CaT1, CaT2, and related cation channels. | 5.52e-05 | 2 | 259 | 2 | 11549322 | |
| Pubmed | 5.52e-05 | 2 | 259 | 2 | 19140341 | ||
| Pubmed | ABCB1/4 gallbladder cancer risk variants identified in India also show strong effects in Chileans. | 5.52e-05 | 2 | 259 | 2 | 32058310 | |
| Pubmed | 5.52e-05 | 2 | 259 | 2 | 32748110 | ||
| Pubmed | 5.52e-05 | 2 | 259 | 2 | 24804815 | ||
| Pubmed | 5.52e-05 | 2 | 259 | 2 | 3768958 | ||
| Pubmed | Role of ABCB1 and ABCB4 in renal and biliary excretion of perfluorooctanoic acid in mice. | 5.52e-05 | 2 | 259 | 2 | 38522903 | |
| Pubmed | Identification and characterization of GSTT3, a third murine Theta class glutathione transferase. | 5.52e-05 | 2 | 259 | 2 | 12038961 | |
| Interaction | TOP3B interactions | GADD45B RAPGEF6 KDM3B CUL9 TSC2 ATG2A PTCH1 ARHGEF11 TTC3 WNK1 LYST SLC52A3 PCNX2 KMT2C TNRC18 XPO6 UNKL HES6 HERC1 ABTB2 IQCE KALRN DOCK9 SAMD4B UBR4 HECTD4 APOB FRYL INO80 HDDC3 NADSYN1 AATK CELSR2 SLC16A5 TLN1 GKAP1 ZFYVE26 IRS2 TNFAIP2 WDFY3 PCNT | 1.26e-06 | 1470 | 254 | 41 | int:TOP3B |
| Interaction | GOLGA1 interactions | RAPGEF6 CCDC18 FAM91A1 ARHGAP29 GOLGB1 UBR4 USP24 VPS54 GCC2 MACF1 CRYBG3 PCNT | 3.76e-06 | 183 | 254 | 12 | int:GOLGA1 |
| Interaction | C1orf87 interactions | 5.28e-06 | 21 | 254 | 5 | int:C1orf87 | |
| Interaction | DSCAM interactions | STAG1 LGR4 CUL9 NEFM TTC7B KALRN SYNE1 VPS54 PDE4DIP MACF1 ROBO1 | 1.15e-05 | 171 | 254 | 11 | int:DSCAM |
| GeneFamily | ATP binding cassette subfamily B | 4.80e-08 | 11 | 186 | 5 | 806 | |
| GeneFamily | Ankyrin repeat domain containing | ANKRD31 ANKRD18B ASAP1 ASB11 NFKBIB ANKDD1B TRPV6 ABTB2 ANKFY1 ANKRD50 ANKRD44 TRPV5 | 8.05e-06 | 242 | 186 | 12 | 403 |
| GeneFamily | PDZ domain containing | 2.82e-05 | 152 | 186 | 9 | 1220 | |
| GeneFamily | Calcium voltage-gated channel subunits|Membrane associated guanylate kinases | 1.36e-04 | 26 | 186 | 4 | 904 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.89e-04 | 206 | 186 | 9 | 682 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 5.81e-04 | 181 | 186 | 8 | 694 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 2.09e-03 | 25 | 186 | 3 | 775 | |
| GeneFamily | Ubiquitin protein ligase E3 component n-recognins | 2.14e-03 | 7 | 186 | 2 | 785 | |
| GeneFamily | Transient receptor potential cation channels | 2.90e-03 | 28 | 186 | 3 | 249 | |
| GeneFamily | CUT class homeoboxes and pseudogenes | 3.61e-03 | 9 | 186 | 2 | 527 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 3.61e-03 | 9 | 186 | 2 | 1230 | |
| GeneFamily | Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors | 3.90e-03 | 31 | 186 | 3 | 81 | |
| GeneFamily | Pleckstrin homology domain containing|SH2 domain containing|C2 and RasGAP domain containing | 4.49e-03 | 10 | 186 | 2 | 830 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 4.76e-03 | 66 | 186 | 4 | 722 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | USP9X TSC2 WNK1 KMT2C TTC7B HERC1 TBCEL USP24 FRYL CELSR2 TLN1 MACF1 ATM | 2.50e-08 | 180 | 254 | 13 | M8239 |
| Coexpression | MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP | IL15 LGR4 PTCH1 WNK1 PTPN4 UNKL NIPBL IQCE GP5 UBR2 SCHIP1 DOCK9 POLR2C FRY ATM | 5.47e-08 | 265 | 254 | 15 | M19170 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DOK5 STAG1 USP9X KDM3B RB1CC1 ITPR1 PJA2 PTPN4 XPO6 ARHGAP29 NIPBL DOP1B UBR2 DMXL2 SCHIP1 DOCK9 USP24 FRYL CASK GCC2 MACF1 WDFY3 CRYBG3 VPS13B CUX1 PCNT PLCE1 | 8.36e-08 | 856 | 254 | 27 | M4500 |
| Coexpression | MULLIGHAN_NPM1_SIGNATURE_3_UP | IL15 LGR4 ARHGEF11 WNK1 PTPN4 UNKL NIPBL IQCE GP5 UBR2 SCHIP1 DOCK9 POLR2C FRY ATM | 1.10e-06 | 335 | 254 | 15 | M10277 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | MCMBP RAPGEF6 USP9X RB1CC1 WNK1 LYST ASAP1 ABCB1 ITPR1 PCNX2 KMT2C PTPN4 XPO6 IL17RA HERC1 TAP1 NIPBL DOCK2 UBR2 SYNE1 DOCK9 UBR4 HECTD4 USP24 NUMA1 YTHDC2 FRYL EPG5 ANKRD44 TLN1 PDE4DIP MACF1 ATM VPS13B MAF | 1.20e-06 | 1492 | 254 | 35 | M40023 |
| Coexpression | GSE41867_NAIVE_VS_DAY6_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN | ABCB4 PHKB FES NIPBL ABTB2 HDDC3 TCP11L2 GKAP1 ATM FLACC1 MAF | 4.42e-06 | 200 | 254 | 11 | M9496 |
| Coexpression | GSE15139_GMCSF_TREATED_VS_UNTREATED_NEUTROPHILS_DN | FAM91A1 PTCH1 OTUB2 SCOC DHX29 SRBD1 PPM1F PDE4DIP CALCRL PCNT | 2.63e-05 | 199 | 254 | 10 | M7099 |
| Coexpression | GSE9037_WT_VS_IRAK4_KO_LPS_1H_STIM_BMDM_UP | MAOA PTCH1 TAF4B DOP1B SAMD4B LZTFL1 ABCB6 HDDC3 ZFYVE26 PCNT | 2.75e-05 | 200 | 254 | 10 | M5815 |
| Coexpression | GSE15324_NAIVE_VS_ACTIVATED_ELF4_KO_CD8_TCELL_DN | CCDC18 TEX10 OTUB2 ABTB2 TRIM45 AATK POLR1E GKAP1 ZNF518B CRYBG3 | 2.75e-05 | 200 | 254 | 10 | M3527 |
| Coexpression | GSE43955_10H_VS_30H_ACT_CD4_TCELL_UP | IGSF8 TRPC6 TRIM21 PCDH12 PTCH1 LYST ABCB4 SCHIP1 MRPS2 SNTB1 | 2.75e-05 | 200 | 254 | 10 | M9689 |
| Coexpression | GSE25123_WT_VS_PPARG_KO_MACROPHAGE_ROSIGLITAZONE_STIM_UP | RAPGEF6 PCDH12 PHKB IQCE ANKFY1 RASGRF1 PALS1 GLCE WDFY3 MAF | 2.75e-05 | 200 | 254 | 10 | M7978 |
| Coexpression | GSE39820_CTRL_VS_TGFBETA3_IL6_IL23A_CD4_TCELL_UP | CCDC18 SMARCAD1 TEX10 ASAP1 HSPA13 INTS7 LRRC40 SKP2 ANKRD44 PALS1 | 2.75e-05 | 200 | 254 | 10 | M5613 |
| Coexpression | ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN | 3.18e-05 | 38 | 254 | 5 | M1751 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | USP9X PCDH12 LYST ABCB1 KMT2C WWC2 SCOC ARHGAP29 SCHIP1 FOXP2 LZTFL1 FRYL USP46 VPS54 PALS1 FRY TCP11L2 PDE4DIP MACF1 CALCRL SNTB1 PLCE1 | 3.34e-05 | 854 | 254 | 22 | M1533 |
| Coexpression | ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN | 5.21e-05 | 42 | 254 | 5 | MM733 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | THAP5 USP9X PTCH1 TTC3 LYST ASAP1 HSPA13 NEFM PJA2 KMT2C TTC7B RABGGTB GOLGB1 DMXL2 RASGRF1 HECTD4 COMMD9 RASA4 SBDS GCC2 PDE4DIP ROBO1 IRS2 | 5.36e-05 | 946 | 254 | 23 | M39169 |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | RRP1B USP9X KDM3B TEX10 TTC3 NME8 STAT6 ABCB1 ABCB4 HSPA13 PHKB PJA2 NIPBL RABGGTB IQCE UBR2 THOC7 DMXL2 ANKFY1 INTS7 NUMA1 LRRC40 GLCE PDE4DIP MACF1 ATM CALCRL | 5.56e-05 | 1215 | 254 | 27 | M41122 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | USP9X PCDH12 LYST ABCB1 KMT2C WWC2 SCOC ARHGAP29 SCHIP1 FOXP2 LZTFL1 FRYL USP46 VPS54 PALS1 FRY TCP11L2 PDE4DIP MACF1 CALCRL SNTB1 PLCE1 | 5.95e-05 | 888 | 254 | 22 | MM1018 |
| Coexpression | GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_DN | 1.01e-04 | 189 | 254 | 9 | M3112 | |
| Coexpression | GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_UP | 1.03e-04 | 10 | 254 | 3 | M13976 | |
| Coexpression | GSE40666_STAT1_KO_VS_STAT4_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_UP | 1.28e-04 | 195 | 254 | 9 | M9218 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN | 1.33e-04 | 196 | 254 | 9 | M41105 | |
| Coexpression | PARENT_MTOR_SIGNALING_UP | CUL9 TSC2 OTUB2 XPO6 IQCE CCHCR1 SYNE1 DOCK9 COQ6 TRIM45 GSTT2 NADSYN1 DNAJC17 FARP1 PDE4DIP SNTB1 | 1.46e-04 | 567 | 254 | 16 | M16909 |
| Coexpression | WINTER_HYPOXIA_DN | 1.47e-04 | 52 | 254 | 5 | M2683 | |
| Coexpression | GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP | 1.49e-04 | 199 | 254 | 9 | M3474 | |
| Coexpression | GSE21927_C26GM_VS_4T1_TUMOR_MONOCYTE_BALBC_DN | 1.49e-04 | 199 | 254 | 9 | M7607 | |
| Coexpression | GSE17721_0.5H_VS_8H_LPS_BMDC_DN | 1.49e-04 | 199 | 254 | 9 | M4075 | |
| Coexpression | GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_UP | 1.54e-04 | 200 | 254 | 9 | M3404 | |
| Coexpression | GSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_UP | 1.54e-04 | 200 | 254 | 9 | M9889 | |
| Coexpression | GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_UP | 1.54e-04 | 200 | 254 | 9 | M7529 | |
| Coexpression | GSE17721_POLYIC_VS_PAM3CSK4_12H_BMDC_UP | 1.54e-04 | 200 | 254 | 9 | M3840 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#4_top-relative-expression-ranked_1000 | WNK1 ABCB1 PCNX2 KMT2C ARHGAP29 HERC1 ABTB2 CACNB2 DMXL2 DOCK9 YTHDC2 | 5.14e-06 | 168 | 250 | 11 | gudmap_developingGonad_P2_ovary_1000_k4 |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | NR2C2 IFT172 PCNX2 PTPN4 ANKDD1B CFAP70 HECTD4 USP24 NUMA1 TCP11L2 KCNQ4 | 3.68e-09 | 166 | 257 | 11 | 32d2eaf8a5d03881bf74d680825af2d5110b082d |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | USP9X RB1CC1 ITPR1 KMT2C HERC1 NIPBL GOLGB1 USP24 EPG5 ANKRD44 MACF1 | 1.35e-08 | 188 | 257 | 11 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 |
| ToppCell | COVID-19-kidney-Epithelial_Doublet|kidney / Disease (COVID-19 only), tissue and cell type | ANKRD31 IQCF1 ANKRD18B AGBL1 DOCK2 CACNA1A CUX2 ABCB5 SDR42E2 | 4.51e-08 | 124 | 257 | 9 | d6f59ddb9b9df02b5201f23fa5fb78f3fd891ee9 |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.34e-07 | 197 | 257 | 10 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.57e-07 | 199 | 257 | 10 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | control-Neutrophil|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | ARHGEF11 ASAP1 TNRC18 FES CD302 IL17RA DMXL2 UBR4 IRS2 TNFAIP2 | 2.70e-07 | 200 | 257 | 10 | b5d197472799cc61d7497faed91ac2564ae4930a |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | TRPC6 IQCJ-SCHIP1 DNAH9 USP46 PALS1 FRY PDE4DIP PLCE1 LARGE1 | 1.23e-06 | 183 | 257 | 9 | 3c516fe5083f02bad1f464ed284010b4131a833c |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | TRPC6 IQCJ-SCHIP1 USP46 PALS1 FRY PDE4DIP ROBO1 PLCE1 LARGE1 | 1.23e-06 | 183 | 257 | 9 | 7c4b775f351794a3de06bd503eecbc8ae8577c44 |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | TRPC6 IQCJ-SCHIP1 DNAH9 USP46 PALS1 FRY PDE4DIP PLCE1 LARGE1 | 1.23e-06 | 183 | 257 | 9 | 9c2689d76fc6d30f5ab093428aa669d0a98953cf |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 1.35e-06 | 185 | 257 | 9 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 1.41e-06 | 186 | 257 | 9 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.61e-06 | 189 | 257 | 9 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-06 | 193 | 257 | 9 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.91e-06 | 193 | 257 | 9 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-06 | 193 | 257 | 9 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-DN_to_DP_transition_(most_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-06 | 193 | 257 | 9 | a6a864644e1b80b7417ea0a27281e79068a3fd3d | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-06 | 193 | 257 | 9 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.00e-06 | 194 | 257 | 9 | 66c056232ac216780acf4cc8ea325bd8ed1909c9 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-06 | 195 | 257 | 9 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-06 | 195 | 257 | 9 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.36e-06 | 198 | 257 | 9 | e1fa02184ce93c4f8aa5cf04b70949cd4c425ff0 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.46e-06 | 199 | 257 | 9 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.46e-06 | 199 | 257 | 9 | 0602e2b2aa56d106da63bd342a38bef437b4d496 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 2.56e-06 | 200 | 257 | 9 | dc344b3ec51d506952e38f0b3a7795d65f9dd4eb | |
| ToppCell | Hematolymphoid-Microglia|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 2.56e-06 | 200 | 257 | 9 | 21bcca3b670fe9bac034aef2275d3de4a9a73e2b | |
| ToppCell | Hematolymphoid-Microglia-TYROBP|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 2.56e-06 | 200 | 257 | 9 | 33036d21c1c82109284473a515c4f890b33fdd5c | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.56e-06 | 200 | 257 | 9 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Hematolymphoid-Microglia-TYROBP----L1-3|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 2.56e-06 | 200 | 257 | 9 | a20dce14f94777687aad57d6fbe3258ad376f63f | |
| ToppCell | Hematolymphoid-Microglia-TYROBP-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 2.56e-06 | 200 | 257 | 9 | 3bba5219453322198e8fdb0921d5f8c403598751 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 2.56e-06 | 200 | 257 | 9 | a8646d0fca99f10827c2d2a12e584660ef7155f1 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.10e-06 | 159 | 257 | 8 | 1472536eea61d4f13033efe42f128bae1614fa74 | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-BM_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.00e-06 | 171 | 257 | 8 | 6f49537f8d3cf18e65aa999fec32ed347ce2da3e | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 7.00e-06 | 171 | 257 | 8 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.00e-06 | 171 | 257 | 8 | ab97ae2b127a585f170f028f1c475cdd1b0cdea5 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.95e-06 | 174 | 257 | 8 | a3f4981b10afa9d41a1c66c7f98522a8a534f82b | |
| ToppCell | PND07-Immune-Immune_Myeloid-Megakaryocyte/Platelet|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.95e-06 | 174 | 257 | 8 | 6cc108dde4b3f98a78a6040280f0d5e4aaa5bd75 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.95e-06 | 174 | 257 | 8 | 4b8bc5568e36031c8ecf001bb646809038c23919 | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-GrB-secreting_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 8.65e-06 | 176 | 257 | 8 | d6e660df92a3d7dd5732171ee623763faf108476 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.01e-06 | 177 | 257 | 8 | 4d2cdb57b427a42085c5f9affa0967b15e84dec3 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_2|390C / Donor, Lineage, Cell class and subclass (all cells) | 9.39e-06 | 178 | 257 | 8 | 829ea00c022a78d1861aa3ec53503272976775d9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.39e-06 | 178 | 257 | 8 | edc7143dc9959d36057cb9471681a23afcbc8cce | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.78e-06 | 179 | 257 | 8 | a3922476f33d2e4137a12dbda21a1703dff79684 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.78e-06 | 179 | 257 | 8 | f5bb4d3a27d56698473219970e764084096cc582 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.78e-06 | 179 | 257 | 8 | fa03ec3cc0132f977b4cb28e7b23789732375183 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.02e-05 | 180 | 257 | 8 | 97e0dcb7cfbba60a782824c5e23995058609fcd4 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-05 | 180 | 257 | 8 | f6a05b3751b01e74b2de8440801b0eb2e723c199 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-05 | 180 | 257 | 8 | dfc75ae4395ff46fbec2c54915d98ead5a1ba1a1 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.02e-05 | 180 | 257 | 8 | 4e9e8cde2919610c4ac0025b1c9819808048bc1d | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.02e-05 | 180 | 257 | 8 | ca2a35bfb67347e47f511589a3d0f763e6664634 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.02e-05 | 180 | 257 | 8 | 466381bf93c3da6a2a241daadb68e9aad2964eae | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.06e-05 | 181 | 257 | 8 | af92b8b7f455210dab502ef6964f3a0162180759 | |
| ToppCell | wk_20-22-Hematologic-Meg-ery-Definitive_erythroblast|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.10e-05 | 182 | 257 | 8 | 0c77ef4556c1d1512ebe9077df858b28f9e38dd5 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-05 | 183 | 257 | 8 | eb559ae3ae252d9365c24ef557dd49b78ed6d898 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-05 | 183 | 257 | 8 | 612d93df03252d4d2ccdce5a9bc162cfd9172a1a | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-05 | 184 | 257 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-05 | 184 | 257 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-05 | 184 | 257 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-05 | 184 | 257 | 8 | 1c857126c0ea0671f0d60b048efca288d348d653 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-05 | 185 | 257 | 8 | 9197f074e769d54031ec41abfc65fcc0c6552c7e | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_Erythro-Mega-Mega-Mast|bone_marrow / Manually curated celltypes from each tissue | 1.24e-05 | 185 | 257 | 8 | a62ebaff92f2ed27b27b32c27c89cfbe2cb35116 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-05 | 185 | 257 | 8 | ce7d62394b09c26ca65b8cdb280afec5e25bbb62 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.29e-05 | 186 | 257 | 8 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.29e-05 | 186 | 257 | 8 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | Control-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 1.34e-05 | 187 | 257 | 8 | 5429ae85942b8ec3895cceb63c663de3c24ca064 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-05 | 188 | 257 | 8 | 1efbc99bcd6542e5d9fa91edb7c4295167914786 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.45e-05 | 189 | 257 | 8 | 1d660bceee449aebf12fc9af4c74af246837b27a | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.57e-05 | 191 | 257 | 8 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.57e-05 | 191 | 257 | 8 | de54dab85db70f847de75b3b6d7667a0e13b9bfb | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.63e-05 | 192 | 257 | 8 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.63e-05 | 192 | 257 | 8 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-05 | 192 | 257 | 8 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | wk_08-11-Hematologic-Meg-ery-Definitive_erythroblast|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.69e-05 | 193 | 257 | 8 | be75abfdf5301cf33df8ee9ed92504d44fdf19a6 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.69e-05 | 193 | 257 | 8 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.69e-05 | 193 | 257 | 8 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 1.75e-05 | 194 | 257 | 8 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-pMON-pMON|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.75e-05 | 194 | 257 | 8 | e237384b02be460d44eeada3026a5691c66f6fc1 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.75e-05 | 194 | 257 | 8 | 49441ca0a8fa34cb847fecbb4b809dd01d879ebb | |
| ToppCell | nucseq-Immune-Immune_Myeloid-pMON|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.75e-05 | 194 | 257 | 8 | 0bc83ae79873a5e473e6e1e3111924cd003986a1 | |
| ToppCell | Monocytes-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 1.75e-05 | 194 | 257 | 8 | fa6a2794baa6be6298f415330ff51b26a5402571 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.75e-05 | 194 | 257 | 8 | cceb7c88492bb6cd531e1c2651638da1ddf30931 | |
| ToppCell | facs-Thymus-nan-3m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-05 | 194 | 257 | 8 | f1661f9f2439fca5c1012c693b0744c4e3b90a9b | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.75e-05 | 194 | 257 | 8 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 1.75e-05 | 194 | 257 | 8 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.75e-05 | 194 | 257 | 8 | de9c7c602d886d0cd8bbd1d7e7744f84df951238 | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D231|Adult / Lineage, Cell type, age group and donor | 1.75e-05 | 194 | 257 | 8 | 800d3d7a9e864d2d6a100a4e4af22f45d5790a8d | |
| ToppCell | facs-Thymus-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-05 | 194 | 257 | 8 | cda1b197efb199330ea7ab25a7cee22cae22589d | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.75e-05 | 194 | 257 | 8 | ea5e1bc8d9e27cabfe1fb833ca47ec0893593b12 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-05 | 195 | 257 | 8 | a1478021a3ed0e779716393124ca2a7770c433b7 | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-myeloid|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.82e-05 | 195 | 257 | 8 | b0dbaae86f5703ab62f925e0f36500274044884a | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.82e-05 | 195 | 257 | 8 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.96e-05 | 197 | 257 | 8 | e567f91fa398fd306d025dcfe89bd50a60216537 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.96e-05 | 197 | 257 | 8 | 9e948b2e0f7e426f1e6f95bbbf4282fbddc2b99d | |
| ToppCell | COVID-19_Severe-Non-classical_Monocyte|World / disease group, cell group and cell class | 1.96e-05 | 197 | 257 | 8 | 60fee75b12451206bb2c07b61651a73c59ec6ade | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.96e-05 | 197 | 257 | 8 | 9244f087ba4b60fdc81d54ce91860de715b3e12c | |
| ToppCell | LV-09._Endothelium_I|LV / Chamber and Cluster_Paper | 1.96e-05 | 197 | 257 | 8 | f9731d4d636e51b94a96805eee6afe9aedc175e3 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.03e-05 | 198 | 257 | 8 | 218f33e068eb126458ec33176de3cfa6fc06ddf0 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class | 2.03e-05 | 198 | 257 | 8 | 76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.03e-05 | 198 | 257 | 8 | 72e8b9cccb7b0a2ea9d415218fff4fa2f09728f4 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.03e-05 | 198 | 257 | 8 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.10e-05 | 199 | 257 | 8 | 9c40b3ee39860e9d8edafd007daec11abdd95435 | |
| Drug | Boldine [476-70-0]; Up 200; 12.2uM; HL60; HT_HG-U133A | PCDH12 ARHGEF11 ABCB4 PCNX2 PTPN4 ALG12 TBCEL UBR4 NUMA1 YTHDC2 GRIK5 SLC16A5 PDE4DIP PLCH1 | 6.35e-08 | 200 | 255 | 14 | 2148_UP |
| Drug | Artemisinin [63968-64-9]; Up 200; 14.2uM; MCF7; HT_HG-U133A | DOK5 MAOA IL17RA KLK5 MVP ALOX12 RASGRF1 CSF1R PPM1F FARP1 IGHMBP2 ZFYVE26 | 2.86e-06 | 200 | 255 | 12 | 7007_UP |
| Drug | Vincristine | GADD45B IL15 MCMBP STAG1 CETP TTC3 WNK1 ABCB1 ITPR1 ABCB4 PCNX2 MVP TAP1 ABTB2 RABGGTB WDR72 LRRC8C CCHCR1 UBR2 CACNB2 UBR4 LZTFL1 HECTD4 ABCB6 YTHDC2 CNKSR2 SKP2 EPG5 NFE2L3 TRIM45 FRY MACF1 | 3.65e-06 | 1182 | 255 | 32 | ctd:D014750 |
| Drug | lamotrigine | 6.47e-06 | 116 | 255 | 9 | CID000003878 | |
| Drug | Cresotic Acid | 7.09e-06 | 12 | 255 | 4 | CID000006738 | |
| Drug | Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A | TRIM21 OTUB2 HERC1 ANKFY1 UBR4 YTHDC2 USP46 MACF1 ZFYVE26 ATM VPS13B | 1.10e-05 | 191 | 255 | 11 | 4168_DN |
| Drug | Fluphenazine dihydrochloride [146-56-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A | GADD45B RRP1B ARHGEF11 WNK1 OTUB2 NFKBIB IL17RA PDE4DIP ATM PLCH1 VPS13B | 1.27e-05 | 194 | 255 | 11 | 3194_DN |
| Drug | Moroxidine hydrochloride [3160-91-6]; Down 200; 19.2uM; MCF7; HT_HG-U133A | 1.33e-05 | 195 | 255 | 11 | 1527_DN | |
| Drug | AC1NSZ76 | 1.37e-05 | 5 | 255 | 3 | CID005320215 | |
| Drug | AC1L2MCS | 1.37e-05 | 5 | 255 | 3 | CID000023441 | |
| Drug | Isopropamide iodide [71-81-8]; Up 200; 8.4uM; MCF7; HT_HG-U133A | ARHGEF11 ITPR1 PCNX2 SPTBN5 SLC9A7 CACNB2 DMXL2 CNKSR2 GRIK5 ANGPTL2 PDE4DIP | 1.40e-05 | 196 | 255 | 11 | 6781_UP |
| Drug | Ceftazidime pentahydrate [78439-06-2]; Up 200; 6.2uM; PC3; HT_HG-U133A | IL15 PCDH12 WNK1 STAT6 TBCEL CACNA1A NUMA1 ANGPTL2 PDE4DIP TNFAIP2 SNTB1 | 1.47e-05 | 197 | 255 | 11 | 5054_UP |
| Drug | Hexamethonium dibromide dihydrate [55-97-0]; Up 200; 10uM; MCF7; HT_HG-U133A | ACADSB PCDH12 ITPR1 PCNX2 NFKBIB ABTB2 INTS7 YTHDC2 CNKSR2 GRIK5 ANGPTL2 | 1.61e-05 | 199 | 255 | 11 | 1482_UP |
| Drug | Trolox [53188-07-1]; Down 200; 16uM; MCF7; HT_HG-U133A | MCMBP SRF ITPR1 CD302 NIPBL ALG12 RABGGTB SKP2 CASK TRIM45 ATM | 1.61e-05 | 199 | 255 | 11 | 2883_DN |
| Drug | gadolinium | IL15 TRPC6 CDH23 ITPR1 TRPV6 CACNA1A AMELY CACNB2 SBDS TNFAIP2 TRPV5 | 1.61e-05 | 199 | 255 | 11 | CID000023982 |
| Drug | Talampicillin hydrochloride [39878-70-1]; Down 200; 7.8uM; PC3; HT_HG-U133A | IL15 KDM5C NOL6 RB1CC1 LYST OTUB2 KLK5 ANKFY1 POLR2C KBTBD4 FARP1 | 1.61e-05 | 199 | 255 | 11 | 7254_DN |
| Drug | AC1O52TI | 1.90e-05 | 15 | 255 | 4 | CID006426890 | |
| Drug | AC1L99H3 | 2.71e-05 | 6 | 255 | 3 | CID000440540 | |
| Drug | v 104 | 2.71e-05 | 6 | 255 | 3 | CID000107262 | |
| Drug | AC1MJ1SO | 3.11e-05 | 33 | 255 | 5 | CID003084042 | |
| Drug | acridone | 3.26e-05 | 17 | 255 | 4 | CID000002015 | |
| Drug | 2-chlorobenzoate | 4.81e-05 | 36 | 255 | 5 | CID000008374 | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A | ARHGEF11 RABGGTB MPP2 ANKFY1 POLR2C NUMA1 IGHMBP2 PDE4DIP IRS2 VPS13B | 5.19e-05 | 187 | 255 | 10 | 6978_UP |
| Drug | moxidectin | 5.22e-05 | 19 | 255 | 4 | CID009571036 | |
| Drug | daunorubicinol | 5.22e-05 | 19 | 255 | 4 | CID000083845 | |
| Drug | Guanfacine hydrochloride [29110-48-3]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 6.20e-05 | 191 | 255 | 10 | 2634_DN | |
| Drug | Carbachol [51-83-2]; Up 200; 21.8uM; MCF7; HT_HG-U133A | TRIM21 NFKBIB KLK5 CACNB2 ANKFY1 SLC16A5 PPM1F IRS2 ATM PLCH1 | 7.06e-05 | 194 | 255 | 10 | 5342_UP |
| Drug | ACNU | 7.15e-05 | 39 | 255 | 5 | CID000039214 | |
| Drug | semustine; Down 200; 100uM; MCF7; HT_HG-U133A | LGR4 WWC2 IQCE POLR2C NUMA1 LAMB1 CEBPZ PPM1F IGHMBP2 PDE4DIP | 7.37e-05 | 195 | 255 | 10 | 7540_DN |
| Drug | NSC759256 | 7.41e-05 | 63 | 255 | 6 | CID000125889 | |
| Drug | tBCEU | 7.46e-05 | 8 | 255 | 3 | CID000164059 | |
| Drug | nicotine glucuronide | 7.46e-05 | 8 | 255 | 3 | CID003035848 | |
| Drug | iodoarylazidoprazosin | 7.46e-05 | 8 | 255 | 3 | CID000115344 | |
| Drug | tXMP | 7.46e-05 | 8 | 255 | 3 | CID003081384 | |
| Drug | Piperacillin sodium salt [59703-84-3]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 7.69e-05 | 196 | 255 | 10 | 3420_UP | |
| Drug | alpha-estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A_EA | GADD45B DOK5 ARHGEF11 ITPR1 SLC9A7 ALG12 CACNB2 SKP2 PDE4DIP IRS2 | 7.69e-05 | 196 | 255 | 10 | 990_UP |
| Drug | Penbutolol sulfate [38363-32-5]; Down 200; 5.8uM; MCF7; HT_HG-U133A | 7.69e-05 | 196 | 255 | 10 | 3534_DN | |
| Drug | Nalbuphine hydrochloride [23277-43-2]; Up 200; 10.2uM; PC3; HT_HG-U133A | ARHGEF11 OTUB2 TAF4B TBCEL INTS7 NUMA1 CASK TRIM45 CELSR2 GLCE | 7.69e-05 | 196 | 255 | 10 | 2063_UP |
| Drug | Naltrexone hydrochloride dihydrate [16676-29-2]; Down 200; 9.6uM; PC3; HT_HG-U133A | WNK1 LYST ARMH3 ALG12 POLR2C NUMA1 SEMA4G CSF1R PDE4DIP WDFY3 | 7.69e-05 | 196 | 255 | 10 | 5765_DN |
| Drug | ICI 182,780; Down 200; 1uM; ssMCF7; HG-U133A | GADD45B RRP1B CUL9 IL17RA NIPBL INTS7 USP24 AATK KBTBD4 PDE4DIP | 7.69e-05 | 196 | 255 | 10 | 523_DN |
| Drug | Thiorphan [76721-89-6]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 8.03e-05 | 197 | 255 | 10 | 2752_DN | |
| Drug | Dicloxacillin sodium salt [13412-64-1]; Up 200; 8.2uM; MCF7; HT_HG-U133A | 8.03e-05 | 197 | 255 | 10 | 3307_UP | |
| Drug | Lincomycin hydrochloride [859-18-7]; Down 200; 9uM; MCF7; HT_HG-U133A | PTCH1 ARHGEF11 OTUB2 NFKBIB MVP DNAJC17 CSF1R TLN1 ATM PLCH1 | 8.37e-05 | 198 | 255 | 10 | 5992_DN |
| Drug | CP-944629 [668990-94-1]; Up 200; 10uM; MCF7; HT_HG-U133A | CUL9 PTCH1 ASAP1 CD302 KLK5 LZTFL1 TRIM45 ANGPTL2 PDE4DIP TNFAIP2 | 8.37e-05 | 198 | 255 | 10 | 7497_UP |
| Drug | Etoposide [33419-42-0]; Down 200; 6.8uM; PC3; HT_HG-U133A | ACADSB NFKBIB NIPBL ALOX12 IQCE TBCEL MPP2 SYNE1 DOCK9 SEMA4G | 8.37e-05 | 198 | 255 | 10 | 6681_DN |
| Drug | Metolazone [17560-51-9]; Up 200; 11uM; HL60; HG-U133A | KDM5C ARHGEF11 STAT6 NFKBIB FES NIPBL IQCE MORC2 ZFYVE26 SNTB1 | 8.37e-05 | 198 | 255 | 10 | 2014_UP |
| Drug | aspirin, USP; Up 200; 100uM; PC3; HT_HG-U133A | PCDH12 WNK1 PCNX2 TRPV6 CACNA1A RASGRF1 CNKSR2 ANGPTL2 IGHMBP2 PDE4DIP | 8.37e-05 | 198 | 255 | 10 | 4428_UP |
| Drug | Lorglumide sodium salt [97964-56-2]; Up 200; 8.4uM; MCF7; HT_HG-U133A | KDM5C TRIM21 NFKBIB TBCEL GP5 AMELY SLC16A5 PDE4DIP IRS2 WDFY3 | 8.73e-05 | 199 | 255 | 10 | 6456_UP |
| Drug | Levodopa [59-92-7]; Down 200; 20.2uM; HL60; HG-U133A | 8.73e-05 | 199 | 255 | 10 | 1972_DN | |
| Drug | SDDs | 1.11e-04 | 9 | 255 | 3 | CID000087190 | |
| Drug | So324 | 1.11e-04 | 9 | 255 | 3 | CID000462261 | |
| Drug | CMPD167 | 1.11e-04 | 9 | 255 | 3 | CID005481119 | |
| Drug | MS-209 | 1.11e-04 | 9 | 255 | 3 | CID000213040 | |
| Drug | HCFC-123 | 1.15e-04 | 23 | 255 | 4 | CID000009385 | |
| Drug | Az 57 | 1.25e-04 | 2 | 255 | 2 | CID000038473 | |
| Drug | mesochlorin e6 monoethylenediamine | 1.25e-04 | 2 | 255 | 2 | CID005488855 | |
| Drug | FU 4 | 1.25e-04 | 2 | 255 | 2 | CID000447053 | |
| Drug | 6-fluorocholesterol | 1.25e-04 | 2 | 255 | 2 | CID000135206 | |
| Drug | 25-fluorocholesterol | 1.25e-04 | 2 | 255 | 2 | CID006454807 | |
| Drug | taxuspine C | 1.25e-04 | 2 | 255 | 2 | CID005321745 | |
| Drug | 2,2-diphenyl-1,3-dioxolane | 1.25e-04 | 2 | 255 | 2 | CID000283230 | |
| Drug | Ro44-5912 | 1.25e-04 | 2 | 255 | 2 | CID000197370 | |
| Drug | 8-(3,3-dimethylallyl)chrysin | 1.25e-04 | 2 | 255 | 2 | CID005281903 | |
| Drug | AC1L8LCS | 1.25e-04 | 2 | 255 | 2 | CID000383419 | |
| Drug | sulfurmycin A | 1.25e-04 | 2 | 255 | 2 | CID000155836 | |
| Drug | 1,9-dideoxyforskolin | 1.25e-04 | 2 | 255 | 2 | ctd:C047983 | |
| Drug | DAPDOX | 1.25e-04 | 2 | 255 | 2 | CID000164413 | |
| Drug | AC1Q6JJG | 1.25e-04 | 2 | 255 | 2 | CID000164322 | |
| Drug | YM212 | 1.25e-04 | 2 | 255 | 2 | CID000129980 | |
| Drug | Ro11-2933 | 1.25e-04 | 2 | 255 | 2 | CID000115215 | |
| Drug | cnidiadin | 1.25e-04 | 2 | 255 | 2 | CID005315980 | |
| Drug | conferone | 1.25e-04 | 2 | 255 | 2 | CID001757335 | |
| Drug | NSC330500 | 1.25e-04 | 2 | 255 | 2 | CID000433448 | |
| Drug | VX-710-3 | 1.25e-04 | 2 | 255 | 2 | CID006450549 | |
| Drug | NAc-LLY-amide | 1.25e-04 | 2 | 255 | 2 | CID000443109 | |
| Drug | 62820-12-6 | 1.25e-04 | 2 | 255 | 2 | CID006449905 | |
| Drug | lanthanum | 1.52e-04 | 136 | 255 | 8 | CID000023926 | |
| Drug | AC1MZ4R5 | 1.57e-04 | 10 | 255 | 3 | CID003842392 | |
| Drug | Emd 51921 | 1.57e-04 | 10 | 255 | 3 | CID000164353 | |
| Drug | diC4PC | 1.57e-04 | 10 | 255 | 3 | CID000193375 | |
| Drug | beryllium fluoride | 1.62e-04 | 103 | 255 | 7 | CID000024589 | |
| Drug | chlorphentermine | 1.89e-04 | 26 | 255 | 4 | CID000010007 | |
| Drug | Ro 4-1284 | 1.89e-04 | 26 | 255 | 4 | CID000009345 | |
| Drug | avermectin | 1.96e-04 | 48 | 255 | 5 | CID006450460 | |
| Drug | dithiane | 2.14e-04 | 11 | 255 | 3 | CID000136335 | |
| Drug | tariquidar | 2.20e-04 | 27 | 255 | 4 | CID000148201 | |
| Drug | ilmofosine | 2.20e-04 | 27 | 255 | 4 | CID000055008 | |
| Drug | Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 2.31e-04 | 183 | 255 | 9 | 5613_DN | |
| Drug | nimodipine | 2.36e-04 | 145 | 255 | 8 | CID000004497 | |
| Drug | trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A | 2.50e-04 | 185 | 255 | 9 | 6916_UP | |
| Drug | IC-1 | 2.83e-04 | 12 | 255 | 3 | CID000049829 | |
| Drug | 3 alpha,6 alpha-dihydroxy-5 beta-cholanoic acid | 2.93e-04 | 29 | 255 | 4 | CID000006747 | |
| Drug | Azlocillin sodium salt [37091-65-9]; Up 200; 8.2uM; MCF7; HT_HG-U133A | 3.04e-04 | 190 | 255 | 9 | 3468_UP | |
| Drug | Harmol hydrochloride monohydrate [40580-83-4]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 3.16e-04 | 191 | 255 | 9 | 6022_DN | |
| Drug | NSC759576 | 3.16e-04 | 191 | 255 | 9 | CID000003075 | |
| Drug | Fluspirilen [1841-19-6]; Up 200; 8.4uM; HL60; HT_HG-U133A | PCDH12 MVP ALG12 RPGRIP1 ANGPTL2 CELSR2 IGHMBP2 TNFAIP2 LARGE1 | 3.42e-04 | 193 | 255 | 9 | 3086_UP |
| Drug | Cyclobenzaprine hydrochloride [6202-23-9]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 3.42e-04 | 193 | 255 | 9 | 4834_UP | |
| Drug | dihydropyridine | 3.42e-04 | 193 | 255 | 9 | CID000104822 | |
| Drug | Glimepiride [93479-97-1]; Down 200; 8.2uM; MCF7; HT_HG-U133A | 3.42e-04 | 193 | 255 | 9 | 4973_DN | |
| Drug | LY 294002; Up 200; 10uM; HL60; HT_HG-U133A | 3.55e-04 | 194 | 255 | 9 | 6195_UP | |
| Disease | Malignant neoplasm of breast | MAOA RB1CC1 TTC3 WNK1 NME8 ABCB1 PHKB ARHGAP29 DNAH9 NIPBL GOLGB1 KIF6 KALRN SYNE1 UBR4 ABCB6 EPG5 CSF1R UNC45B PPM1F FARP1 MACF1 ROBO1 ZFYVE26 ATM FLACC1 VPS13B CUX1 | 9.14e-08 | 1074 | 244 | 28 | C0006142 |
| Disease | aspartate aminotransferase measurement | ANKRD31 IL15 MCMBP RAPGEF6 CETP PTCH1 ABCB1 ITPR1 ABCB4 WWC2 ARHGAP29 ABTB2 CACNB2 CUX2 KALRN LZTFL1 HECTD4 TBC1D8 CSF1R PCDHGB4 ROBO1 CALCRL PLCE1 | 2.08e-06 | 904 | 244 | 23 | EFO_0004736 |
| Disease | neuroimaging measurement | STAG1 SMARCAD1 PTCH1 TTC34 ARHGEF11 NEFM PTPN4 IQCJ-SCHIP1 AGBL1 MPP2 CACNB2 THOC7 KIF6 FOXP2 DOCK9 CNKSR2 FRYL RFC5 MACF1 ROBO1 CALCRL PLCH1 PLCE1 MAF | 1.03e-05 | 1069 | 244 | 24 | EFO_0004346 |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | ANKRD31 CETP MPP2 HECTD4 USP24 APOB NFE2L3 CMIP CELSR2 MACF1 SNTB1 | 1.39e-05 | 264 | 244 | 11 | EFO_0008317, EFO_0020944 |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 2.79e-05 | 144 | 244 | 8 | EFO_0004611, EFO_0020943 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 3.74e-05 | 150 | 244 | 8 | EFO_0004611, EFO_0020947 | |
| Disease | cystic fibrosis (implicated_via_orthology) | 4.52e-05 | 9 | 244 | 3 | DOID:1485 (implicated_via_orthology) | |
| Disease | Bipolar Disorder | DOK5 MAOA ITPR1 NEFM ALOX12 CACNA1A CACNB2 CUX2 RASGRF1 SYNE1 DOCK9 GRIK5 USP46 PCNT | 4.89e-05 | 477 | 244 | 14 | C0005586 |
| Disease | cholesteryl esters to total lipids in small VLDL percentage | 5.26e-05 | 49 | 244 | 5 | EFO_0022256 | |
| Disease | cholesterol to total lipids in small VLDL percentage | 6.39e-05 | 51 | 244 | 5 | EFO_0022242 | |
| Disease | Charcot-Marie-Tooth disease (biomarker_via_orthology) | 6.81e-05 | 2 | 244 | 2 | DOID:10595 (biomarker_via_orthology) | |
| Disease | triglycerides to total lipids in very large VLDL percentage | 7.70e-05 | 53 | 244 | 5 | EFO_0022340 | |
| Disease | cholesteryl esters to total lipids in very large VLDL percentage | 7.70e-05 | 53 | 244 | 5 | EFO_0022258 | |
| Disease | fatty acid measurement | ANKRD31 STAG1 CETP CEP128 UGT2B17 UBR2 APOB GRIK5 NFE2L3 CMIP CELSR2 GKAP1 MACF1 | 7.76e-05 | 436 | 244 | 13 | EFO_0005110 |
| Disease | serum gamma-glutamyl transferase measurement | STAG1 IFT172 ARHGEF11 ITPR1 WWC2 NFKBIB SLC9A7 CUX2 KALRN HECTD4 GSTT2B SEMA4G TBC1D8 NFE2L3 CELSR2 TLN1 ROBO1 TNFAIP2 FLACC1 PLCE1 | 8.18e-05 | 914 | 244 | 20 | EFO_0004532 |
| Disease | triglycerides in medium HDL measurement | 8.43e-05 | 54 | 244 | 5 | EFO_0022321 | |
| Disease | cholesterol to total lipids in very large VLDL percentage | 8.43e-05 | 54 | 244 | 5 | EFO_0022244 | |
| Disease | cholesterol to total lipids in large HDL percentage | 9.22e-05 | 55 | 244 | 5 | EFO_0022234 | |
| Disease | cholesteryl esters to total lipids in large VLDL percentage | 1.01e-04 | 56 | 244 | 5 | EFO_0022250 | |
| Disease | free cholesterol to total lipids in medium VLDL percentage | 1.09e-04 | 57 | 244 | 5 | EFO_0022284 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 1.15e-04 | 225 | 244 | 9 | EFO_0008317, EFO_0020947 | |
| Disease | Mental Disorders, Severe | 1.16e-04 | 12 | 244 | 3 | C4046029 | |
| Disease | Diagnosis, Psychiatric | 1.16e-04 | 12 | 244 | 3 | C0376338 | |
| Disease | Behavior Disorders | 1.16e-04 | 12 | 244 | 3 | C0004930 | |
| Disease | Mental disorders | 1.16e-04 | 12 | 244 | 3 | C0004936 | |
| Disease | triglycerides to total lipids in small VLDL percentage | 1.19e-04 | 58 | 244 | 5 | EFO_0022338 | |
| Disease | phospholipids:total lipids ratio | 1.23e-04 | 227 | 244 | 9 | EFO_0020946 | |
| Disease | free cholesterol to total lipids in medium HDL percentage | 1.40e-04 | 60 | 244 | 5 | EFO_0022282 | |
| Disease | DEAFNESS, AUTOSOMAL RECESSIVE (disorder) | 1.50e-04 | 13 | 244 | 3 | C1846647 | |
| Disease | C-reactive protein measurement, high density lipoprotein cholesterol measurement | 1.74e-04 | 34 | 244 | 4 | EFO_0004458, EFO_0004612 | |
| Disease | triglycerides to total lipids in medium VLDL percentage | 1.76e-04 | 63 | 244 | 5 | EFO_0022335 | |
| Disease | lymphangioleiomyomatosis (is_implicated_in) | 2.03e-04 | 3 | 244 | 2 | DOID:3319 (is_implicated_in) | |
| Disease | Refractive Errors | 2.03e-04 | 3 | 244 | 2 | C0034951 | |
| Disease | Ametropia | 2.03e-04 | 3 | 244 | 2 | C1527310 | |
| Disease | total lipids in very large HDL measurement | 2.20e-04 | 66 | 244 | 5 | EFO_0022312 | |
| Disease | Hypertriglyceridemia | 2.36e-04 | 15 | 244 | 3 | C0020557 | |
| Disease | Benign Neoplasm | 2.53e-04 | 68 | 244 | 5 | C0086692 | |
| Disease | Neoplasms | 2.53e-04 | 68 | 244 | 5 | C0027651 | |
| Disease | free cholesterol in large VLDL measurement | 2.53e-04 | 68 | 244 | 5 | EFO_0022265 | |
| Disease | cholesterol in very large HDL measurement | 2.71e-04 | 69 | 244 | 5 | EFO_0022229 | |
| Disease | triglycerides to total lipids in large VLDL percentage | 2.99e-04 | 39 | 244 | 4 | EFO_0022332 | |
| Disease | non-high density lipoprotein cholesterol measurement | CETP ABCB4 UGT2B17 HFM1 WDR72 CACNA1A APOB GRIK5 TBC1D8 NFE2L3 CMIP CSF1R CELSR2 GCC2 PLCE1 MAF | 3.21e-04 | 713 | 244 | 16 | EFO_0005689 |
| Disease | lipoprotein-associated phospholipase A(2) measurement | 3.30e-04 | 40 | 244 | 4 | EFO_0004746 | |
| Disease | cholesterol to total lipids in chylomicrons and extremely large VLDL percentage | 3.49e-04 | 17 | 244 | 3 | EFO_0022232 | |
| Disease | antihyperlipidemic drug use measurement | 3.99e-04 | 115 | 244 | 6 | EFO_0803367 | |
| Disease | free cholesterol to total lipids in small VLDL percentage | 4.00e-04 | 75 | 244 | 5 | EFO_0022287 | |
| Disease | Chronic Liver Failure | 4.04e-04 | 4 | 244 | 2 | C2936476 | |
| Disease | End Stage Liver Disease | 4.04e-04 | 4 | 244 | 2 | C0745744 | |
| Disease | Chediak-Higashi syndrome (implicated_via_orthology) | 4.04e-04 | 4 | 244 | 2 | DOID:2935 (implicated_via_orthology) | |
| Disease | nephrotic syndrome type 2 (is_implicated_in) | 4.04e-04 | 4 | 244 | 2 | DOID:0080379 (is_implicated_in) | |
| Disease | very low density lipoprotein cholesterol measurement, esterified cholesterol measurement | 4.16e-04 | 18 | 244 | 3 | EFO_0008317, EFO_0008589 | |
| Disease | axial length measurement | 4.52e-04 | 77 | 244 | 5 | EFO_0005318 | |
| Disease | sodium-coupled monocarboxylate transporter 1 measurement | 4.91e-04 | 19 | 244 | 3 | EFO_0802076 | |
| Disease | cholesterol to total lipids in large VLDL percentage | 5.21e-04 | 45 | 244 | 4 | EFO_0022236 | |
| Disease | sleep duration, high density lipoprotein cholesterol measurement | 5.23e-04 | 121 | 244 | 6 | EFO_0004612, EFO_0005271 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 5.51e-04 | 222 | 244 | 8 | EFO_0008317, EFO_0020943 | |
| Disease | alcohol drinking | 5.70e-04 | 81 | 244 | 5 | EFO_0004329 | |
| Disease | platelet component distribution width | WNK1 ASAP1 ANKDD1B HERC1 ALG12 IQCE GP5 KALRN SYNE1 DOCK9 GCC2 TLN1 MACF1 IRS2 CUX1 MAF | 5.97e-04 | 755 | 244 | 16 | EFO_0007984 |
| Disease | cholesteryl esters to total lipids in chylomicrons and extremely large VLDL percentage | 6.65e-04 | 21 | 244 | 3 | EFO_0022246 | |
| Disease | urinary pH measurement | 6.70e-04 | 5 | 244 | 2 | EFO_0010136 | |
| Disease | insulin-like growth factor-binding protein 1 measurement | 6.70e-04 | 5 | 244 | 2 | EFO_0020474 | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 6.76e-04 | 127 | 244 | 6 | EFO_0008595, EFO_0020947 | |
| Disease | Malignant Neoplasms | 7.04e-04 | 128 | 244 | 6 | C0006826 | |
| Disease | myocardial infarction | 7.19e-04 | 350 | 244 | 10 | EFO_0000612 | |
| Disease | choline measurement | 7.63e-04 | 130 | 244 | 6 | EFO_0010116 | |
| Disease | Hepatitis | 7.66e-04 | 22 | 244 | 3 | HP_0012115 | |
| Disease | proprotein convertase subtilisin/kexin type 9 measurement | 7.66e-04 | 22 | 244 | 3 | EFO_0009312 | |
| Disease | Medulloblastoma | 7.79e-04 | 50 | 244 | 4 | C0025149 | |
| Disease | triglycerides to total lipids in medium LDL percentage | 7.79e-04 | 50 | 244 | 4 | EFO_0022334 | |
| Disease | total cholesterol measurement, diastolic blood pressure, triglyceride measurement, systolic blood pressure, hematocrit, ventricular rate measurement, glucose measurement, body mass index, high density lipoprotein cholesterol measurement | 8.40e-04 | 51 | 244 | 4 | EFO_0004340, EFO_0004348, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928 | |
| Disease | cholesterol to total lipids in small HDL percentage | 8.40e-04 | 51 | 244 | 4 | EFO_0022240 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 9.91e-04 | 243 | 244 | 8 | EFO_0004612, EFO_0020944 | |
| Disease | childhood trauma measurement | 9.94e-04 | 24 | 244 | 3 | EFO_0007979 | |
| Disease | coronary artery disease | ANKRD31 STAG1 RRP1B CETP TTC34 FES WDR72 CUX2 DOCK9 HECTD4 LRRC40 CNKSR2 APOB INO80 ANKRD50 SKP2 EPG5 CMIP CELSR2 FARP1 PLCE1 | 9.99e-04 | 1194 | 244 | 21 | EFO_0001645 |
| Disease | glucagon measurement, glucose tolerance test | 9.99e-04 | 6 | 244 | 2 | EFO_0004307, EFO_0008463 | |
| Disease | mental or behavioural disorder, substance abuse | 9.99e-04 | 6 | 244 | 2 | EFO_0000677, MONDO_0002491 | |
| Disease | Lissencephaly | 9.99e-04 | 6 | 244 | 2 | C0266463 | |
| Disease | pallidum volume | 1.12e-03 | 25 | 244 | 3 | EFO_0006933 | |
| Disease | mental development measurement | 1.12e-03 | 25 | 244 | 3 | EFO_0008230 | |
| Disease | C-reactive protein measurement | CETP IFT172 ITPR1 SLC9A7 HFM1 TAF4B WDR72 RPGRIP1 UBR2 CACNB2 DMXL2 CUX2 YTHDC2 APOB ANKRD44 CMIP LINGO1 CELSR2 MACF1 IRS2 CUX1 | 1.13e-03 | 1206 | 244 | 21 | EFO_0004458 |
| Disease | lymphocyte count | CDH23 ARHGEF11 LYST ITPR1 PTPN4 XPO6 HFM1 DOCK2 LRRC8C CCHCR1 ZFAT PCDHGB5 KALRN PCDHGA2 HECTD4 GRIK5 NFE2L3 CMIP TLN1 PCDHGB4 ATM CALCRL FLACC1 PLCE1 | 1.16e-03 | 1464 | 244 | 24 | EFO_0004587 |
| Disease | response to statin | 1.20e-03 | 56 | 244 | 4 | GO_0036273 | |
| Disease | cholesterol to total lipids in large LDL percentage | 1.20e-03 | 56 | 244 | 4 | EFO_0022235 | |
| Disease | LDL cholesterol change measurement | 1.39e-03 | 7 | 244 | 2 | EFO_0007804 | |
| Disease | catalase measurement | 1.39e-03 | 7 | 244 | 2 | EFO_0008071 | |
| Disease | infertility (implicated_via_orthology) | 1.39e-03 | 7 | 244 | 2 | DOID:5223 (implicated_via_orthology) | |
| Disease | cholesterol to total lipids in small LDL percentage | 1.41e-03 | 27 | 244 | 3 | EFO_0022241 | |
| Disease | cholesteryl ester measurement | 1.42e-03 | 257 | 244 | 8 | EFO_0010351 | |
| Disease | cholesterol in medium HDL measurement | 1.45e-03 | 59 | 244 | 4 | EFO_0021903 | |
| Disease | free cholesterol to total lipids in very large VLDL percentage | 1.45e-03 | 59 | 244 | 4 | EFO_0022289 | |
| Disease | neurotic disorder | 1.54e-03 | 101 | 244 | 5 | EFO_0004257 | |
| Disease | cholesterol to total lipids in IDL percentage | 1.55e-03 | 60 | 244 | 4 | EFO_0022233 | |
| Disease | Autistic Disorder | 1.56e-03 | 261 | 244 | 8 | C0004352 | |
| Disease | preterm premature rupture of the membranes, spontaneous preterm birth | 1.57e-03 | 28 | 244 | 3 | EFO_0006917, MONDO_0012511 | |
| Disease | Bell's palsy | 1.61e-03 | 102 | 244 | 5 | EFO_0007167 | |
| Disease | respiratory failure, COVID-19 | 1.74e-03 | 29 | 244 | 3 | EFO_0009686, MONDO_0100096 | |
| Disease | Mental Retardation, X-Linked | 1.74e-03 | 29 | 244 | 3 | C1136249 | |
| Disease | free cholesterol in very large HDL measurement | 1.75e-03 | 62 | 244 | 4 | EFO_0022273 | |
| Disease | familial hyperlipidemia (is_implicated_in) | 1.85e-03 | 8 | 244 | 2 | DOID:1168 (is_implicated_in) | |
| Disease | PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME | 1.85e-03 | 8 | 244 | 2 | C0796250 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ATIIANCIVLALEQH | 106 | O00555 | |
| SLNIVEAAVHAENLI | 1636 | Q9HCE0 | |
| IALETSTQVALDHLE | 956 | Q6ZU80 | |
| ISHLSIASSQVELVE | 81 | P11597 | |
| SHSQAINVDRIALVL | 36 | Q99218 | |
| IHNIAVTENELAVIT | 296 | Q86XM0 | |
| ILERLLEAAVQQHST | 6 | Q9UKL4 | |
| TNIIALQRHAVTDTE | 491 | Q68DQ2 | |
| THRLSAIQNADLIVV | 1211 | Q2M3G0 | |
| DNHILISALVIASTV | 166 | Q8IX05 | |
| QEVINELFVTEASHL | 736 | O15085 | |
| AEVESLHSNLATAIN | 426 | A2A2Z9 | |
| NLTTQEHENIIVAIA | 216 | Q8IY22 | |
| AVVATLHLSEATENN | 231 | Q9Y2Z9 | |
| VAHRLSTVVNADQIL | 781 | Q9NP58 | |
| VAHVATQLEAARLLT | 336 | P45954 | |
| NHISQLSEEQVLEVV | 611 | Q5T2E6 | |
| THINQLQLLSTIDES | 581 | O94923 | |
| ELTIQVTSLHAALEQ | 321 | Q5VSY0 | |
| LATLAHNQSEIIAQL | 186 | Q9UKU9 | |
| ALHLINSNLQLETAE | 456 | Q9ULJ7 | |
| VNLVTINRVSSLHEA | 91 | Q8WXH4 | |
| IVLASTHDVQELDVT | 2676 | Q8TDJ6 | |
| ALATLTILVTDTNDH | 271 | Q9HCU4 | |
| IALHSILSTQDQAAA | 901 | Q7Z478 | |
| DVQHLQSSLQELEEA | 316 | O14529 | |
| IATVNITLLDINDNH | 761 | Q9H251 | |
| QLQELLSAVSLTDHE | 296 | Q2TAZ0 | |
| QTDVLLHIDVAAAQT | 386 | Q9BV10 | |
| HQLLAQAATLLSAEE | 1051 | Q96MI9 | |
| RTLQLVVLDADTINH | 366 | Q08289 | |
| AEVLEQSAQTLRAHL | 406 | O43374 | |
| STILAAIVNHLQNSI | 441 | P49116 | |
| SLSTDAHILLQVADI | 431 | Q9Y5H1 | |
| AEVLEQSAQTLRAHL | 406 | C9J798 | |
| LVVALDVDATLEHVQ | 841 | Q96HW7 | |
| VETLLTQLHSAQDAA | 431 | Q9NVH2 | |
| QEEAIVIIQSALRAH | 601 | Q6IPM2 | |
| TANQLHLQLEILLDS | 176 | Q8N6M8 | |
| AIDATVAAELLNHLL | 116 | Q96HZ4 | |
| HTEVVCNILLLDNTV | 26 | P29074 | |
| VQSIALLAHLAEREN | 551 | Q9ULG1 | |
| ATLHLVFADSLQEVL | 656 | Q9UN71 | |
| LATGDLALIHVEIQV | 111 | Q9NPG4 | |
| AHRLSTIQNADLIVV | 1231 | P08183 | |
| HVDQSSDNIIIETLN | 246 | P21397 | |
| LSVHQTLSAILQDIE | 1326 | Q8N7Z5 | |
| LANNLEDIASTLVRH | 696 | Q9P2R3 | |
| HVAVQNSDIESVLFL | 876 | Q9P2R3 | |
| HVRNIIALSIEATAA | 986 | Q8TAB3 | |
| DHIQITALSQALSIA | 176 | Q96DC9 | |
| EQTIHQVSLDLDSLA | 711 | Q8TDY2 | |
| AVSQVLDSLEEIHAL | 346 | O14936 | |
| NITVETLEAHQLRVS | 206 | Q96F46 | |
| HEQSVLVAAILAIAV | 186 | Q8NGF6 | |
| HLIADSIAEQILATL | 171 | O95461 | |
| QELNSALHQTDLIDI | 166 | O00370 | |
| ETASDLLLHSALVQE | 526 | P58215 | |
| LLIAVSSQHTVNTEL | 601 | Q8NEZ4 | |
| LQAVVHSEVESELIN | 61 | Q9NQ48 | |
| EDAVEALISNSHQLQ | 111 | O75444 | |
| EELHAQALILESLNT | 341 | Q96Q35 | |
| LHSQVESLAEVVLQN | 491 | P61550 | |
| HESNGIDIITALILN | 2066 | Q14643 | |
| SIHDTVENLIILANN | 106 | P40933 | |
| NVAISTLLEVINHSQ | 811 | Q9Y3R5 | |
| TLLEVINHSQSLALV | 816 | Q9Y3R5 | |
| DIVVLQAALLHDTVE | 51 | Q8N4P3 | |
| SIDEHTNVAELANVL | 261 | Q658Y4 | |
| LSLCNDVIHTAIEVV | 186 | Q15751 | |
| SVLSTIQEHQELANE | 116 | P56696 | |
| AQHTLQALQSELDSL | 526 | Q13948 | |
| LAQLSQEDVVLHSES | 201 | Q96HB5 | |
| SNDIVNIVLHNLSSA | 2156 | Q5CZC0 | |
| NIVLHNLSSAATLVI | 2161 | Q5CZC0 | |
| HLAVEAQAADVLELL | 246 | Q15653 | |
| LASDDLNAFVHLIEI | 1421 | A6NKB5 | |
| EVEHVVNAILFLLSD | 211 | Q7Z4W1 | |
| SSEVSTVELLHLQQQ | 41 | O15409 | |
| AAQTTIETAIHSLIE | 2896 | O94915 | |
| SQAISQDVNLHEAIL | 306 | Q9Y4A8 | |
| SISHIESVLQQLDDA | 736 | O60229 | |
| LVSQLVHSLNQVSTD | 61 | Q6KC79 | |
| IEVAHSSLQIVLALA | 146 | Q5VXU1 | |
| VLQDTVLESHLQLLS | 301 | Q9H6R4 | |
| NLTLHQATTEEEALN | 186 | Q6ZMV9 | |
| QILLEHAALRETVNA | 166 | Q7LBC6 | |
| HAALRETVNALISDQ | 171 | Q7LBC6 | |
| VESLSQVEVILQHSA | 1551 | P07942 | |
| VTSTLENEEHSQIII | 506 | Q9BXB1 | |
| HLEELELNENIVSAV | 96 | Q96FE5 | |
| AALAIAEQHERLLQS | 226 | Q9P104 | |
| ITALLLGVTEHVLAN | 16 | Q9Y337 | |
| AEQSSTAAELAHILQ | 106 | Q14168 | |
| LDVVALLINHGAEVT | 186 | Q8N8A2 | |
| TASQLTNVILHLAQE | 381 | Q9NQG6 | |
| LLNTHLVAEVIAVAT | 361 | P18054 | |
| SISVILHIRDVNDNA | 431 | Q9Y5G0 | |
| EEAITTNEVINQLLH | 216 | Q9Y4D8 | |
| CQEAHSIILSILEQA | 206 | P0CG30 | |
| QLLSVTAELEARHQA | 911 | O95613 | |
| VITIETADHARLQLQ | 526 | Q14764 | |
| QQENLDTLEHLVTEL | 4271 | Q9UPN3 | |
| ELLANTELVEHITAA | 791 | Q9UG01 | |
| IAHRLSTIQNADLIV | 1236 | P21439 | |
| LSTNHETIDLLVQIL | 901 | Q9Y6X9 | |
| NAEIVLHTITDVNIA | 701 | A2PYH4 | |
| HTLVDSQSQEDISLL | 136 | Q8N3R9 | |
| LAITSQLHQVNSDLL | 201 | P53611 | |
| DSVVAQNIHETILEA | 276 | Q9Y4H2 | |
| ALLNDIESSHLLQQT | 266 | Q52LW3 | |
| IESSHLLQQTIAALQ | 271 | Q52LW3 | |
| LVLHSIQGLQEDSVL | 286 | P0C7X3 | |
| SVTQEEAEELLQALH | 51 | Q9P000 | |
| ILINEQSAELVHIDL | 2876 | Q13315 | |
| HIANILNSEELDIQD | 596 | P04114 | |
| VTVQSLLTVETLEHN | 466 | P07333 | |
| ANIQHLSSRSLVNIV | 346 | Q7L8L6 | |
| AVLAHVDVQTLSSQL | 291 | Q969P0 | |
| LDAAHASITNELQTV | 396 | Q8NCX0 | |
| INTLTHNLQTLEEEN | 506 | Q8NCX0 | |
| HLAVAFITQDSLQLE | 1031 | Q92608 | |
| VLHQSLLEANIATEV | 1386 | Q9BZ29 | |
| DNLVQAHILASEALR | 226 | Q8WUS8 | |
| VTVSAAVLSDHNLEI | 276 | P0C221 | |
| QDLLTDLHALQVTIT | 146 | A6NNT2 | |
| LELEEAQDTVSNLHQ | 1261 | Q5T9S5 | |
| AALLISHIVQSEIGD | 156 | Q9Y4F1 | |
| EALLAEIHTLQETVG | 1101 | Q5T0N1 | |
| EDDIALQIHFTLIQS | 66 | O75293 | |
| CQEAHSIILSILEQA | 206 | P0CG29 | |
| VSELQTLQSEHDTLL | 1376 | Q8IWJ2 | |
| TADQTSLHLVDFLVQ | 611 | Q9ULH1 | |
| QEQLSSLTQAHEEAL | 176 | Q8TD31 | |
| SLHATAELLQVRVQS | 286 | Q8TD31 | |
| ELFHQLSQALEVLTD | 51 | Q9NVM6 | |
| ELQHISSINVEEVSA | 1066 | Q99698 | |
| DEAVTHLDDQILQLT | 116 | Q9Y2E5 | |
| LSSLESVQLDHNQLE | 386 | P40197 | |
| SLDQHVAAVVATVQI | 676 | Q8IWT3 | |
| LHQSAQLSVLLTVEE | 301 | P48723 | |
| ALVDLQLHTEAQAQI | 411 | Q96AY2 | |
| LVQAHVLAAEALTTA | 251 | A6NKP2 | |
| AHSLQCDLSVILEQV | 166 | Q9NYC9 | |
| LLTQTLVEALENHNE | 2776 | Q9NYC9 | |
| LEHQLSEVALQTALA | 1846 | Q5TBA9 | |
| DVLTECLVLQQLHTS | 366 | Q8NBF1 | |
| IVLANSSLDIVLHDT | 356 | P00395 | |
| VSTIIIDANASISHL | 211 | Q16478 | |
| LSEAIHLLQVAGETV | 716 | Q9C0E4 | |
| TTVSQITAIEAQHLL | 256 | P13807 | |
| LQNIEEATQHELTIE | 171 | A0A1B0GTI1 | |
| SDILTNQALESQEHL | 696 | Q9C0D2 | |
| LDLNQHELSAIQEVE | 1841 | Q9C0D2 | |
| DLDEVLQTHSVFVNV | 46 | Q9Y3A5 | |
| ILLTVEDISHLNSTQ | 581 | Q16820 | |
| TIIHLTAVANNQALV | 191 | Q16602 | |
| ATETIEDALLHLAQQ | 21 | Q8N815 | |
| QDDAVHTLQFVETLV | 256 | Q03701 | |
| SAIHILDVLVLNGTD | 656 | Q8N1G2 | |
| NDLVVHVALIAESQR | 491 | Q93100 | |
| ALTVLDIHDNQLTSL | 106 | Q9H9A6 | |
| QSITADDLHQLLVVA | 586 | Q9BTE3 | |
| AAALAHEAVSQLLQT | 76 | P49593 | |
| LQLEHTSTQALVSEL | 1346 | Q14980 | |
| LTAQVRSLEAQVAHA | 1676 | Q14980 | |
| FIETSATLQHNVAEL | 221 | O75628 | |
| LEISSLVQDEVVAIH | 231 | P07332 | |
| LQLNELTVESVQHTL | 296 | P07332 | |
| VLLGVSSAEQLIEHL | 361 | O43448 | |
| ETLLDVLVAVLQAHA | 156 | O60391 | |
| VTALVSDAIHNDLQD | 181 | Q9GZS1 | |
| HDITELNSDAVNLIS | 671 | Q92750 | |
| THDQAVVLQSALQSI | 1191 | Q93008 | |
| SLQLDVQIASEHASL | 471 | Q6ZRF8 | |
| SAIHSNVNDLLTRVI | 291 | Q13884 | |
| ALEEALAQIHIINSA | 251 | Q9H8W5 | |
| SSVSNEEISQEHIII | 1341 | Q8TEU7 | |
| LSQVLNELQVSHAET | 501 | Q96KN7 | |
| NELQVSHAETTLELE | 506 | Q96KN7 | |
| SVEDLLNDQVTLHSI | 251 | Q9NQ40 | |
| QEELANTIAQLVHAV | 71 | Q14684 | |
| SIHELAVILGDQLTA | 686 | Q8TF05 | |
| INLTSANVVILHDID | 936 | Q9H4L7 | |
| NLSNLTLAHEIAVNE | 71 | Q8N4U5 | |
| ELAFQLHQLTVLASV | 226 | Q5H9J9 | |
| QALLNSVLHTREDVI | 3546 | Q8NF91 | |
| QLEELQILLTEATNH | 5356 | Q8NF91 | |
| LLVSSLDEHVATVTQ | 751 | Q6IEE7 | |
| LVDEVHSNLLVVDQT | 301 | Q6ZMQ8 | |
| LHNEVLEISSLFINS | 1971 | Q9P212 | |
| LNDLISHQDILSTIQ | 31 | P40937 | |
| VNDLHSQIESLNEEL | 431 | P0DPB3 | |
| ALERSSSAQEALHVI | 121 | Q96FV2 | |
| AHNRVIVLQDVSESV | 81 | Q9NVX7 | |
| TTEALLQHLDSALQA | 171 | Q13635 | |
| LNLFVTSLDATVNHV | 281 | P31391 | |
| VLLITQHLSLVEQAD | 696 | Q03518 | |
| INQVLELQHTLEDLS | 101 | Q9UIL1 | |
| VTTAVQELLRLAQAH | 961 | Q15477 | |
| IVNDLHSQIESLNEE | 506 | B3KU38 | |
| HSQIESLNEELVQLL | 511 | B3KU38 | |
| HLTSVIQNTDILDDA | 36 | Q7Z745 | |
| IDLEQTATHLQLALN | 116 | Q9Y399 | |
| NHSALEIAEQLTLLD | 1036 | Q13972 | |
| TLQDIEIGVQHILAD | 361 | Q8N5C6 | |
| LSDLQTQLSHEIQSD | 256 | P19387 | |
| LSLLQEVEAASHQLE | 536 | Q9NRC6 | |
| LTELQVVNLDTAHST | 491 | P11831 | |
| ISVVQLLLDAGAHVE | 581 | Q8N961 | |
| VVNSLLSAQHDIDIL | 316 | A6NHY2 | |
| NTLADQVDTTHELLT | 121 | Q9BWW9 | |
| LVSQSAHLEVIQLAN | 206 | Q8WXI2 | |
| VAVAHVSETITQLNL | 276 | Q13309 | |
| LEAAESLVLEQSFLH | 1371 | O15417 | |
| TDQLVAVEALIHAST | 436 | Q8IWX7 | |
| STHAQDIVQIITDAL | 596 | Q9P2K2 | |
| CHSELAIDIIQITSQ | 356 | Q03169 | |
| ILQQIIELGAETHDA | 1131 | Q9P243 | |
| SSHFADISLIENQIL | 591 | Q6AWC2 | |
| LAVANILQSLVHTER | 876 | Q8IZQ1 | |
| LAEIQHQSTSDLLTE | 241 | Q8N443 | |
| HQELLSTLTQTQVAA | 86 | Q5TG30 | |
| ESQSVENLVISLLQH | 476 | Q9NTN9 | |
| ILHFAVAEADNIVTL | 61 | Q8N427 | |
| HSVDEQQAALLISII | 266 | O15375 | |
| HLLESEANSAAIVSQ | 56 | Q5PRF9 | |
| LIQDARDAIVHTLQA | 166 | A6NJB7 | |
| LLESIQQHSLDAVLA | 271 | P38935 | |
| ATAVTQALNELLQHV | 771 | Q9Y490 | |
| QLTLEQLHAVEISAV | 116 | Q9BRJ7 | |
| NLASALLSDTVQHLQ | 51 | P42226 | |
| NSESIHQSLETQEVL | 211 | Q7Z6K1 | |
| EHILASLLTEQSLVN | 1086 | O95759 | |
| TEAIQAVLLAEVQQH | 986 | Q3MJ13 | |
| AQDSLGNTVLHILIL | 231 | Q9H1D0 | |
| HLDQSLEISNTLTNE | 1601 | P53804 | |
| IIDAHLSNILSEVTA | 91 | Q9NXF1 | |
| TQLIDIIHTAAARAN | 571 | Q9NXF1 | |
| TALVNVALNLSIHQD | 231 | Q8WVM7 | |
| AVSHNASLEVAILRD | 156 | Q9Y6N7 | |
| LSTIHELQQTLENDE | 171 | Q6I9Y2 | |
| CHSSALELLQEVIIV | 236 | P19474 | |
| VISHLIDNVTLTNEN | 1176 | Q4KWH8 | |
| ALDLHLSNVNIASLE | 421 | Q9H9P5 | |
| QLDVHEQSTIQELLS | 341 | Q9H0C1 | |
| SNHLAVVLDDIILAV | 346 | Q96K49 | |
| AQVFHLILTENVSVD | 486 | Q9H6S0 | |
| LDLSVDVEQNTSITH | 196 | P62068 | |
| SSLIQQALEEHLTIL | 566 | Q9UPU5 | |
| LLVLHSDVSSQRNVA | 2346 | Q9UPU5 | |
| ILRDAVQVNSTAHEV | 786 | Q86TV6 | |
| QVDTDENILLASLHS | 2646 | Q7Z7G8 | |
| TFLAVLSHLDIITQN | 1246 | Q13395 | |
| ALQLAVANEHLEITE | 136 | Q9Y210 | |
| AQHASVSLETSLVIE | 1671 | Q9H4A3 | |
| DLIDVHAQSLAALQA | 616 | Q96QU8 | |
| HQTLSVLEDIVENIS | 786 | Q96QU8 | |
| TVLAIFNELHADVDL | 266 | Q96T83 | |
| AHIIQILLTSCTEEN | 1451 | Q8IWV8 | |
| QLVASVIESESEILH | 51 | Q5T4S7 | |
| VHLALDQLQEAVDDI | 221 | A8MYJ7 | |
| LEVTEQSLDQHTSLA | 1611 | Q68DK2 | |
| LAHLESLAVDVEVAN | 591 | O43164 | |
| SLDTLVLANNHLNAI | 201 | Q5QJ74 | |
| HEVIVLTSSASILVN | 51 | O75795 | |
| AQDSLGNTVLHILIL | 191 | Q9NQA5 | |
| EEELINSVVISQLSH | 481 | P49815 | |
| VEVNIAHQISLRSEA | 216 | Q9P1Q0 | |
| AVLRVLNSSENAHII | 776 | Q9C0D4 | |
| DNLLTEQIHSLSIEA | 791 | Q14789 | |
| VIQDVLAAGSHLQLL | 111 | Q96NJ5 | |
| VLEQSVLCHINADIS | 481 | P41229 | |
| AIAVAHSSQVRVLNL | 166 | Q5JTD7 | |
| ATIAQLDNLQELSLH | 461 | Q8TDW0 | |
| TLVTNENLHELDLSN | 721 | Q86W25 | |
| DTLLHSFQVLAALVE | 61 | Q6IA69 | |
| ITQQSVSDSHLAELQ | 231 | Q5VU43 | |
| EVADLLAQIQASHIT | 241 | P07197 |